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ABSTRACT 
Public interest in botanical supplements has increased greatly in recent years as various plant 
materials might be used for anti-inflammatory, immunostimulatory, antioxidant and cancer 
preventive effects.  Our long term goal is to improve our understanding of the 
characteristics of phytochemicals that contribute to human health benefits on gut functions, 
and thereby pave the way for optimizing herbal supplements for study in future clinical trials.  
In this dissertation, the overarching hypotheses were that major components of the ethanolic 
extracts of Echinacea, alkamides and ketones, and caffeic acid derivatives in the ethanolic 
extract of Prunella vulgaris, will be transferred by Caco-2 cell monolayers and caffeic acid 
derivatives will enhance the intestinal epithelial barrier function. 
 
Echinacea has long been used as phytotherapy for wound healing, pain relief and treatment 
of the common cold.  In the first study, Bauer alkamides, the key components contained in 
Echinacea sanguinea and Echinacea pallida, transferred across the Caco-2 cell monolayer 
via passive diffusion, independent of other constituents in plant extract.   The apparent 
permeability coefficients (Papp) were 2.8 ± 1.5- 43.8 ± 11.2 cm/s ×10-6 for tested three 
alkamides and the order of the transfer of them across Caco-2 cells was increased paralleled 
with compound hydrophicility.  Tested alkamides were seemingly N-glucuronidated and 
both Echinacea extracts stimulated apparent glucuronidation and basolateral efflux of 
alkamide metabolites.  Bauer ketone 24 was totally metabolized to more hydrophilic 
metabolites as a pure compound, but not found in either Echinacea species.  The addition of 
Bauer alkamides (175-230 µM) as well as the ethanolic extracts of E. sanguinea at 1 mg/mL 
(containing 85 µM of alkamide 8, 2 µM of alkamide 10, and 0.7 µM of alkamide 11) and E. 
pallida at 5 mg/mL (containing 215 µM of alkamide 8, 25 µM of alkamide 10, and 45 µM of 
alkamide 11) reduced the efflux of the P-glycoprotein transporter (P-gp) probe calcein-AM 
x 
   
from Caco-2 cells.  These results suggest that other constituents in the plant extract had a 
facilitating effect on the metabolism and efflux of alkamides and ketones from Echinacea, 
which would improve the therapeutic benefits of these extracts, and that alkamides and 
Echinacea extracts might be useful in potentiating some chemotherapeutics which are 
substrates for P-gp. 
 
Prunella vulgaris is a perennial herb known as self-heal used to treat sore throat, fever, and 
wounds.  Rosmarinic acid is a caffeic acid derivative found in various botanicals, especially 
in P. vulgaris.  Ursolic acid, a pentacyclic triterpene acid, is also found in P. vulgaris but 
especially concentrated in Salvia officinalis (sage), which has been traditionally used to treat 
inflammation in the oral cavity, and may also be of interest in inhibiting gastrointestinal 
inflammation which is relevant to colitis and colon cancer.  In the second study, Papp for 
rosmarinic acid and rosmarinic acid in P. vulgaris extracts was 0.2 ± 0.05 × 10-6 cm/s, 
significantly increased to 0.9 ± 0.2 × 10-6 cm/s after β-glucuronidase/sulfatase treatment.  
Papp for ursolic acid and ursolic acid in S. officinalis extract was 2.7 ± 0.3 × 10-6 cm/s and 2.3 
± 0.5 × 10-6 cm/s before and after β-glucuronidase/sulfatase treatment, respectively.  
Neither compound was affected in permeability by the herbal extract matrix.  These results 
indicate that rosmarinic acid and ursolic acid in herbal extracts had similar uptake as that 
found using the pure compounds, which may simplify the prediction of compound efficacy, 
but the apparent lack of intestinal glucuronidation/sulfation of ursolic acid is likely to further 
enhance the bioavailability of that compound compared with rosmarinic acid. 
 
In the third study, the effects of caffeic acid and related compounds on intestinal barrier 
function were investigated using Caco-2 cells as a model.  Caffeic acid, rosmarinic acid, 
chlorogenic acid and m-hydroxyphenylpropionic acid (mHPP, a microbial metabolite of 
xi 
   
caffeic acid and rosmarinic acid) up-regulated the expression of zonula occludens (ZO -1), 
ZO-2, claudin-1 and occludin in Caco-2 cells.  In addition, chlorogenic acid and mHPP 
were effective against adverse effects induced by inflammatory stimuli (LPS, interferon-γ, 
IL-1β, and TNF-α) on tight junction proteins in Caco-2 cells.  Caffeic acid derivatives 
up-regulated claudin-4 in P-glycroprotein transporter MDR1- knockdown (KD) Caco-2 cells 
and only mHPP was effective against the changes in tight junction protein expression 
induced by inflammatory stimuli in MDR KD Caco-2 cells.  Caffeic acid derivatives 
augmented TNF-α and IL-6 levels in Caco-2 cells under the stimulated condition, but 
significantly reduced both cytokines in MDR KD caco-2 cells plus the stimuli.  These 
results indicate that caffeic acid derivatives enhanced barrier function in human intestinal 
Caco-2 cells and mHPP exhibited greater enhancement of intestinal barrier than the parent 
compounds.  P-gp plays an essential role in the anti-inflammatory activities of caffeic acid 
derivatives. 
 
In conclusion, these data confirmed the overarching hypotheses and suggest that the effect of 
plant matrix on bioavailability and metabolism of the constituent is compound specific, 
depending on the transfer mechanism; and caffeic acid derivatives could be gut health 
promoting as a dietary constituent, but these compounds might exacerbate damage under 
inflammatory stimuli.  Moreover, intake of caffeic acid derivatives might speed up mucosal 
recovery or provide protection to the small-intestinal mucosa against the inflammatory 
mediators when P-gp inhibitors are co-administered, which may be attractive from a 
therapeutic point of view. 
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CHAPTER 1. GENERAL INTRODUCTION 
Introduction 
Echinacea supplements were the most commonly used nonvitamin, nonmineral, natural 
products both for adults and children according to 2007 NHIS survey (National Health 
Interview Survey, 2007).  Species of Echinacea, such as E. angustifolia, E. pallida, E. 
sanguinea and E. purpurea, have immune modulatory (Borchers et al., 2000), antiviral 
(Pleschka et al., 2009), and antibacterial activities (Sharma et al., 2010).  Several 
alkamides from the roots of E. angustifolia and E. pallida have suppressed the expression 
of cyclooxygenase 2 (COX-2) and prostaglandin E 2 (PGE2) formation in H4 human 
neuroglioma cells (Hinz et al., 2007) and lipopolysaccharide (LPS) stimulated RAW264.7 
macrophages.  Bauer ketones 23 and 24 at 2.6 and 5 µM, respectively, were identified as 
significant contributors to the PGE (2) inhibition by E. pallida root extract at 25 µg/mL 
(LaLone et al., 2007).  E. pallida root and aerial extracts at 2 mg/mL exhibited ~50% 
inhibition of 2, 2-diphenyl-2-picrylhydrazyl (DPPH) radical and the order of the 
antioxidant activities of the phenolics in E. pallida extract was echinacoside (EC50 = 6.6 
μM) > cichoric acid (8.6 μM) > cynarin (11.0 μM) > chlorogenic acid (18.9 μM) > caffeic 
acid (19.1 μM) > caftaric acid (20.5 μM).  The efficacy of Echinacea species may be 
related to the bioavailability of its constituents.  In a randomized crossover single-dose 
study, 10 volunteers were orally administered standardized tincture of E. purpurea or 
twelve E. purpurea tablets, and both doses contained 0.07 mg of the major alkamides.  
Alkamides derived from the Echinacea tincture were detectable in serum within 30 min 
after administration and their concentration peaked at 0.4 ng/ml; alkamides in tablets 
reached a level of 0.12 ng/ml in serum 45 min after ingestion (Woelkart et al., 2006).  
However, caffeic acid conjugates (caftaric acid, cichoric acid and echinacoside) were not 
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detected in any plasma sample at any time after ingestion of Echinacea tablets 
manufactured from an ethanolic liquid extract in a human study (Matthias et al., 2005).  
 
The genus Prunella (Lamiaceae), a perennial herb that is widely distributed throughout 
Asia and Europe, is used primarily as a traditional botanical medicine to reduce 
osteoarthritis, rheumatoid arthritis, and gingivitis (Song et al., 2007; Adámková et al., 2004; 
Jung et al., 2001).  Rosmarinic acid (RA), one of the key constituent contained in Prunella, 
was found to exhibit anti-inflammatory and antioxidative properties (Huang et al., 2009; 
Psotova et al., 2003).  Rosmarinic acid might be poorly absorbed in the small intestine 
because when Perilla extract containing 200 mg of RA was orally administered to six men, 
RA in both plasma and urine was present predominantly as glucuronide and/or sulfate 
conjugated forms, at 0.6 ± 0.2% and 1.5 ± 0.4% of the total intake, respectively, within 48 h 
after ingestion (Baba et al., 2005).  Gut microbes may metabolize RA to give phenolics 
such as caffeic acid, o-coumaric acid and m-hydroxyphenylpropionic acid, which are then 
absorbed by monocarboxylic acid transporter (MCT)-mediated active processes (Konishi 
and Kobayashi, 2005).   
 
Until now, studies have not been carried out to investigate the effects of plant extracts on 
the bioavailability and metabolism of alkamides, ketones and caffeic acid derivatives, nor 
have the mechanisms of the protection of caffeic acid derivatives on intestinal function 
been investigated.  In this whole project, we focused our research interest in these less 
explored areas.  The overarching hypotheses were that alkamides, ketones and caffeic acid 
derivatives will be transferred by Caco-2 cell monolayers and caffeic acid derivatives will 
enhance the intestinal barrier function.  We conducted these studies to test three individual 
hypotheses within two main research fields: bioavailability and metabolism of botanical 
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constituents in vitro (Hypothesis and objective 1 and 2) and modulation of caffeic acid 
derivatives on intestinal function (Hypothesis and objective 3). 
 
1. In the first study, we hypothesized that Bauer alkamides and ketones would be 
absorbed similarly as pure compounds or as part of complex plant extracts (E. 
sanguinea and E. pallida), and that these Echinacea extracts could inhibit 
P-glycoprotein (P-gp) transporter in Caco-2 human intestinal epithelial cells.  Caco-2 
cells were incubated with pure alkamides and ketone as well as with the two extracts 
that contain the specific alkamides to determine the permeability and metabolism of 
those key constituents both in pure solutions and in herbal extracts.  Efflux of the P-gp 
probe calcein-AM across Caco-2 cells was assessed to study the inhibtion of P-gp 
function by pure compounds and two extracts. 
2. In the second study, our hypotheses were that the absorbability and metabolism of 
rosmarinic acid and ursolic acid was independent of the plant extract matrix. This study 
was also designed to investigate the permeability of rosmarinic acid and ursolic acid as 
pure compounds in comparison to the permeability of these compounds when added as 
a complex mixture in the form of P. vulgaris and S. officinalis ethanol extracts across 
Caco-2 cell monolayers.  It is anticipated that the results of these studies will provide a 
foundation for future studies of to assess the efficacy of these herbs as therapeutic 
strategies to treat gastrointestinal inflammation. 
3. In the third study, our hypothesis was that caffeic acid , rosmarinic acid, chlorogenic 
acid and m-hydroxyphenylpropionic acid (mHPP), a microbial metabolite of caffeic 
acid and rosmarinic acid, will alter the intestinal barrier function in Caco-2 human 
intestinal epithelial cells and P-gp transporter, encoded by multidrug resistance (MDR1) 
gene, knockdown (KD) Caco-2 cells.  Stimuli composed of interleukin (IL)-1β, tumor 
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necrosis factor (TNF)-α, interferon (IFN)-γ and lipopolysaccharides (LPS) were added 
to the cell system to represent acute inflammatory reactions and mimic inflammatory 
bowel disease.  Tight junction protein expression and immune modulator excretion in 
both Caco-2 cell model and MDR knockdown (MDR KD) Caco-2 cells were measured. 
 
Dissertation Organization 
 
The contents of this thesis includes an introduction, which is comprised of a general 
introduction and a literature review that delves into the phytochemical profile, health 
benefits, bioavailability and metabolism of the key constituents in Echinacea and Prunella 
vulgaris ethanolic extracts.  Chapter 3 consists of a manuscript that will be submitted to 
the Journal of Planta Medica entitled “Glucuronidation of alkamides and ketones in 
Echinacea sanguinea and Echinacea pallida extracts by Caco-2 cells and their modulation 
of P-glycoprotein transporter”.   Co-authors on this manuscript include: Basil J. Nikolau, 
mentored Ludmila Rizshsky and provided the phytochemical profile in Echinacea 
ethanolic extracts using GC-MS; Patricia A. Murphy and Cathy Hauck worked on the 
extraction process for the Echinacea extracts; Mark P. Widrlechner and Joe-Ann McCoy 
provided all Echinacea plant material; Manju B. Reddy, mentored Zhiyi Qiang on Caco-2 
cell culture; Suzanne Hendrich, mentored Zhiyi Qiang and provided guidance and edits to 
all research conducted and manuscript drafts.  Chapter 4 consists of a manuscript 
submitted to the Journal of Ethnopharmacology entitled “Metabolism and permeability of 
rosmarinic acid in Prunella vulgaris and ursolic acid in Salvia officinalis extracts across 
Caco-2 cell monolayers”.   Co-authors on this manuscript include: Patricia A. Murphy 
and Cathy Hauck worked on the extraction process for the P. vulgaris extracts; Mark P. 
Widrlechner and Joe-Ann McCoy provided all P. vulgaris plant material; Manju B. Reddy, 
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mentored Zhiyi Qiang and Zhong Ye on Caco-2 cell culture; Suzanne Hendrich, mentored 
Zhiyi Qiang and Zhong Ye and provided guidance and edits to all research conducted and 
manuscript drafts.  Chapter 5 consists of a manuscript that will be submitted to the Journal 
of Nutrition entitled “Caffeic acid derivatives enhanced epithelial barrier integrity and 
exhibited anti-inflammatory activities in P-glycoprotein transporter knockdown Caco-2 
cells”.  Co-authors on this manuscript include: Diane Birt, mentored Nan Huang and 
provided the guidance on Western Blot analysis of tight junction proteins and ELISA 
analysis of cytokines in Caco-2 cells; Kazuya Maeda, provided P-glycoprotein knockdown 
Caco-2 cells; Manju B. Reddy mentored Zhiyi Qiang on Caco-2 cell culture; Suzanne 
Hendrich, mentored Zhiyi Qiang and Li Li and provided guidance and edits to all research 
conducted and manuscript drafts.  Finally, chapter 6 contains a general conclusion and 
recommendations for future research.
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CHAPTER 2. LITERATURE REVIEW 
1. GENERAL INTRODUCTION OF BOTANICAL MEDICINE 
Botanical medicine, or phytomedicine, has become a promising area in US, an alternative 
to conventional medicine.  Human use of botanical medicine has a long history, whose 
record can date back to about 60,000 years ago (Solecki, 1975).  It is estimated that as 
much as 80% of the world population still depends on herbal medicines to meet primary 
healthcare, mainly for particular diseases or symptoms based on the properties of a 
particular botanical (van Wijk, 2000).  Indeed, medicinal herbs play an essential role in 
drug development as ~30% of all current medical drugs sold worldwide contain 
compounds derived from plant material (FAO, 2004).  In the US, herbal medicine is 
classified as dietary supplements, which are consumed without prescription.  Notable 
examples of the botanical dietary supplements used widely in the US today include 
Echinacea, garlic, ginkgo biloba, ginseng, and St. John’s wort with the sales over 100 
million annually. 
 
2. OVERALL INTRODUCTION OF ECHINACEA SANGUINEA AND PALLIDA 
The genus of Echinacea is a perennial herb that is native to North America and grouped 
within the Asteraceae family.  Historically, Echinacea preparations have been used by 
Native Americans to relieve pain and to treat various conditions such as snakebites and 
wounds.  Early European settlers learned of its medicinal effects, and expanded its uses in 
treatment of infectious diseases (Borchers et al., 2000).  Today, Echinacea products are 
mainly used for reducing the duration and/or the symptoms associated with the common 
cold and other upper respiratory infections, although clinical trials have not established 
efficacy (Barrett et al., 2010; Turner et al., 2005).  It is estimated that Americans spend 
over $100 million per year on Echinacea products and their sales make up 10% of the total 
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US herbal market (Islam and Carter, 2005).  Echinacea supplement was the most 
commonly used nonvitamin, nonmineral, natural products both for adults and children 
according to 2007 NHIS survey (National Health Interview Survey, 2007).  The nine 
species of Echinacea that have been characterized are E. angustifolia, E. pallida, E. 
purpurea, E. sanguinea, E. simulata, E. tennesseensis, E. laevigata, E. atrorubens, and E. 
paradoxa, with each possessing its own unique phytochemical components (Miller and Yu, 
2005).  The diversity, or in some cases similarity, of the constituents present in these 
Echinacea species contributes to the diverse bioactivities associated with the botanical 
Echinacea.  
 
2.1 Phytochemistry of E. sanguinea and E. pallida 
A wide range of phytochemicals have been found in Echinacea, some of which have been 
reported to have bioactivity.  These include alkamides and ketones (Bauer, 2002; 
Woelkart et al., 2005), caffeic acid derivatives, such as caffeic acid, chlorogenic acid, 
caftaric acid, echinacoside, etc. (Cheminat et al., 1988, Figure 1), polysaccharides (Orinda 
et al., 1973), and glycoproteins (Egert and Beuscher, 1992).  
 
Figure 1 Structure of common alkamides, ketones, and caffeic acid derivatives found in 
Echinacea species 
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E. angustifolia, E. sanguinea, E. purpurea, and E. tennesseensis ethanolic extracts (15 
μg/mL of each) were analyzed by HPLC showing greater quantities of Bauer alkamides 
than ketones or caffeic acid derivatives.  The concentration range of Bauer alkamides 3, 
8-14 and 17 were 0.1-2.8 μM.  Ketones were present around 0.1 μM.  Cichoric acid and 
caftaric acid were present around 0.07-0.28 μM and 0.01-0.04 μM, respectively (LaLone et 
al., 2007).  Another study investigated the metabolite distribution in E. pallida methanolic 
extract (15 μg/mL) and found that alkamide 1/2, 3 and 4 were contained at 1.5, 0.7 and 0.4 
μM, but ketones, including ketone 19-28, were present at 30.5 -52.4 μM (Hou et al., 2010), 
10 fold greater than the quantity of alkamides, but caffeic acid derivatives were not 
determined in this study.  Pellati et al. (2004) report the total phenolic content for E. 
angustifolia, E. pallida, and E. purpurea to be 10.49 mg/g, 17.83 mg/g, and 23.23 mg/g, 
respectively.  E. pallida methanolic extract (10 μg/mL) contained 2.5 μM, 20.3 μM and 
1.7 μM of caftaric acid, echinacoside, and cichoric acid, respectively (Figure 1).  
Although many of the active compounds of Echinacea have been identified, relative 
potency, mechanism of action, bioavailability and metabolism are less known. 
 
2.2 Health benefits of E. sanguinea and E. pallida 
E. pallida is one of the most medicinally used Echinacea species in the US and Europe and 
is being introduced into other regions due to the increasing popularity in alternative herbal 
remedies.  E. sanguinea has been neglected in the scientific literature, however, Birt et al., 
(2008) reported that E. sanguinea ethanolic extract had greater anti-inflammatory activity 
in terms of the significant reduction of prostaglandin E 2 (PGE2) production in 
lipopolysaccharide (LPS) stimulated RAW264.7 macrophages, than E. angustifolia, E. 
pallida, and E. simulata.  In addition, our preliminary experiments showed that alkamide 8, 
10, 11 and ketone 24 were only present in E. pallida and E. sanguinea ethanol extracts, but 
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not in E. angustifolia and E.simulata ethanolic assessions.  Therefore, E. pallida and E. 
sanguinea were choosen in this study to investigate their absorption, metabolism and health 
benefits. 
 
2.2.1 Anti-inflammatory effects 
E. angustifolia, E. pallida, and E. simulata have been described to possess an 
anti-inflammatory activity which was differed from species, extracts, and fractionation and 
contributed to main constituents (LaLone et al., 2007; Birt et al., 2008).  Treatment with 
echinacoside at 0.5 µM, a caffeic acid derivative from root extract of E. pallida at 100 
mg/mL, inhibited the signs of inflammation injected by 1 ml of a gel (1% ethylcellulose) on 
the dorsal area of the rats for 48 and 72 h (Speroni et al., 2002).  Bauer ketones 23 and 24 
at 2.6 and 5 µM, respectively, were identified as significant contributors to the PGE (2) 
inhibition by E. pallida root extract at 25 µg/mL.  Three different alkamides (alkamide 5, 
alkamide 7 and alkamide 8) from the root of E. angustifolia have suppressed the expression 
of cyclooxygenase 2 (COX-2) and PGE2 formation at sites of inflammation in H4 human 
neuroglioma cells (Hinz et al., 2007), but E. pallida root extract did not show any 
suppressive effect on COX-2 promoter activity at 50 µg/mL at both transcriptional and 
translational levels in 12-O-tetradecanoylphorbol -13-acetate (TPA) stimulated RAW 
264.7 cells, human breast adenocarcinoma MCF-7 cell as well as mouse models (Hou et al., 
2010).  Combinations of different alkamides in Echinacea extracts might play a 
synergistic role in the inhibition of PGE2 production in LPS-stimulated RAW264.7 mouse 
macrophage cells.  Active extracts containing < 2.8 μM of combined alkamides in 15 
μg/mL of E. angustifolia, E. pallida, E. simulata, and E. sanguinea extracts significantly 
have inhibited PGE2 production (LaLone et al., 2007).  In a summary, different species of 
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Echinacea had an effective anti-inflammatory action and the anti-inflammatory activity 
was mainly contributed to alkamides or caffeic acid derivatives. 
2.2.2 Anti-oxidant effects 
Assessing free radical scavenging was mainly used to evaluate the antioxidant capacity in 
medicinal plants and other nutritional antioxidant supplements.  Echinacea extracts have 
been reported to be free radical scavengers and possess anti-oxidant properties.  The roots 
of E. purpurea, E. angustifolia and E. pallida exhibited significant free radical scavenging 
capabilities by the inhibition of Fe2+-induced lipid peroxidation (Sloley et al., 2001).  E. 
pallida root and aerial extracts at 2 mg/mL exhibited ~50% inhibition of 2, 
2-diphenyl-2-picrylhydrazyl (DPPH) radical and displayed ~55% of Fe2+-chealating power 
(Orhan et al., 2009).  Capacities to quench DPPH radicals of phenolic compounds in 
Echinacea species indicated that echinacoside (EC50 = 6.6 μM) > cichoric acid (8.6 μM) > 
cynarin (11.0 μM) > chlorogenic acid (18.9 μM) > caffeic acid (19.1 μM) > caftaric acid 
(20.5 μM), which might be due to the number of hydroxyl groups on the aromatic ring as 
the more hydroxyl groups, the greater the radical scavenging activity (Wang et al., 2003).  
Alkamide 2 and 8 inhibited Cu (II)-catalyzed oxidation of human low-density lipoprotein 
in vitro and showed a synergistic effect with caffeic acid derivatives, and polysaccharides 
(Dalby-Brown et al., 2005).  In a summary, Echinacea species had an effective antioxidant 
capacity across species and extracts; the antioxidant capacity was attributed to ability to 
scavenge free radical.  
 
2.2.3 Anti-viral effects 
Echinacea extracts and its metabolic constituents possessed antiviral activities (Cheminat 
et al., 1988), but the results are very controversial.  Hydroalcoholic root extract of E. 
pallida (100 µg/mL) exhibited high levels of antiviral activity against both types of herpes 
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simplex virus types 1 and 2 (HSV-1, HSV-2) analyzed by plaque reduction assays 
(Schneider et al., 2009).  Interleukin-2 is required for the clonal expansion and activation 
of T cells during viral infection and has also been linked to decreased symptoms and 
reduction of virus revival in experimental rhinovirus infection in human Jurkat T cells 
(Sasagawa et al., 2006).  Aerial extract of E. purpurea at 50 µg/mL inhibited IL-2 
production by ~65% and Bauer alkylamide 9 and Bauer alkylamide 11 at ~2 µM were both 
capable of inhibiting IL-2 production in Jurkat E6.1 T cells (Sasagawa et al., 2006).   
 
In a human study, supercritical carbon dioxide, 60 % ethanol, or 20 % ethanol extracts of E. 
angustifolia root did not show any statistically significant effects on rhinovirus infection 
and severity of symptoms in 437 volunteers, measured by the volume of nasal secretions, 
polymorphonuclear leukocyte or interleukin-8 concentrations in nasal-lavage specimens, 
as well as quantitative-virus titer (Turner et al., 2005).  The conflicting results might be 
because the dose of Echinacea extract was not be adequate to show protection against 
rhinovirus infection.   However, aqueous-ethanolic E. purpurea extract induced a 
statistically significant increase in the survival rate, prolonged the mean survival time and 
reduced lung consolidation and virus titer after 6 days of intranasal infection with Influenza 
A virus in mice (Bodinet et al., 2002). Fusco et al. (2010) also showed that E. purpurea 
polysaccharide extract had lower systemic and pulmonary keratinocyte chemoattractant 
(KC) and interleukin (IL)-10 levels and lower systemic interferon-γ (IFN-γ) levels 
following influenza infection compared with controls in mice.  Therefore, more and larger 
human studies are needed for the anti-viral effect of Echinacea extracts, and the dose, 
species and type of Echinacea extract, time to initiation of treatment, virus type as well as 
immune competence of volunteers should be considered. Meanwhile, more investigations 
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are critically required on the absorption and metabolism data regarding the various 
constituents of different Echinacea species. 
 
2.3 Bioavailability of E. sanguinea and E. pallida chemical constituents 
A major weakness with most in vitro studies dealing with botanicals and bioactivity is 
accounting for how much of the particular extract or compound actually enters the cells or 
the body of the model being studied.  Therefore, it is essential to investigate the 
bioavailability of the diverse constituents contained in Echinacea species.  Most of the 
published papers were focusing on the bioavailability and pharmacokinetics of different 
alkamides and caffeic acid derivatives in human and cell culture models.  
 
Alkamides 8 (Figure 1) from Echinacea species has been reported to transport through 
human adenocarcinoma colonic cell line Caco-2 monolayer at 30 minutes after apical 
loading of 25 μg/ml and about 15 % of these alkamides were detectable on the basolateral 
side, which was not affected by lipopolysaccharide or phorbol 12-myristate-13-acetate in 
order to mimic an inflammatory state (Jager et al., 2002). In another study, twelve 
alkylamides were shown to readily cross Caco-2 monolayers (apparent permeability >10-6 
cm/s), and 2, 4-dienes were more readily transported than the equivalent 2-ene alkamides 
(Matthias et al., 2004).  Among the tested caffeic acid derivatives, cinnamic acid, caftaric 
acid, cichoric acid, echinacoside, and tartaric acid exhibited poor uptake through the 
Caco-2 monolayers (less than 5% transported).  Chicca et al. (2008) also used the Caco-2 
system to study the permeability of ketones from E. pallida extract.  Bauer ketone 22 and 
24 were readily permeable through the cell system, with ketone 22 showing the highest 
apparent permeability at 32 ± 3 × 10-6 cm/s. 
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In a randomized crossover study, six healthy adults of both sexes consumed 4 g of 
Echinacea powder mixture which contained E. angustifolia, E. purpurea, and E. pallida.  
The 24 h urinary recovery of cichoric acid of E. purpurea and E. pallida were 0.36 ± 0.25 
and 0.34 ± 0.31 % of ingested dose (Lee et al., 2006).  However, another human study did 
not detect caffeic acid conjugates (caftaric acid, cichoric acid and echinacoside) in any 
plasma sample at any time after ingestion of Echinacea tablets manufactured from an 
ethanolic liquid extract, whereas alkamides were detected in plasma 20 minutes after tablet 
ingestion (Matthias et al., 2005).  In a randomized crossover single-dose study, 10 
volunteers were orally administered either 4 ml of the standardized E. purpurea tincture or 
twelve E. purpurea tablets, and both doses contained 0.07 mg of the major alkamides.  
Alkamides in Echinacea tincture in serum were present at 0.4 ng/ml 30 min after 
admnistration, whereas alkamides in tablets were 0.12 ng/ml serum after 45 min (Woelkart 
et al., 2006).  Similar bioavailability of alkylamides was found from the liquids (200 and 
300 mg/ml) and tablets (600 and 675 mg/tablet) Echinacea formulations in a two-way 
crossover study in humans (Matthias et al., 2007).  Taken together, these results indicate 
that alkamides, as well as certain ketones, are likely to cross the intestinal barrier and be 
bioavailable in humans, and therefore, should be able to carry out their bioactivities in vivo, 
but caffeic acid derivatives are less likely to do so. 
 
2.4 Metabolism of E. sanguinea and E. pallida 
Due to potential interactions with other herbal supplements or pharmaceuticals, it is 
necessary to understand how bioactive constituents from Echinacea are metabolized in the 
liver or in other tissues.  Cytochrome P450 (CYP) may affect the metabolism and further 
bioavailability of Echinacea constituents.  Matthias et al. (2005) studied the metabolism 
of the alkamide constituents from Echinacea premium liquid, a mixture of 200 mg/mL of E. 
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angustifolia and 300 mg/mL of E. purpurea 60% ethanol/water root extracts, in human 
liver microsomes and provided evidence that NADPH dependent cytochrome P450 
metabolized the 2-ene and 2, 4-dienes in the ethanolic extracts of Echinacea.  
Monohydroxylated, monoepoxidized, N-dealkylated metabolites were determined after 
incubation of parent Bauer alkamides with both NADPH and human liver microsomes.  
Further results from this study showed that 60% ethanol/water extract of E. purpurea 
containing 16 μM of Bauer alkylamides 8/9 significantly suppressed IL-2 secretion by 47% 
in the Jurkat T cells, but the suppression of IL-2 secretion was significantly lessened when 
NADH was added with the same treatment, indicating the importance of understanding the 
metabolism of constituents found in Echinacea and how it affects different bioactivities.   
 
Echinacea preparations have been found to affect metabolizing enzyme activities and 
transporter functions in vitro, implying the importance regarding herb–drug interactions.  
E. purpurea extract inhibited CYP3A4 activity, tested by the inhibition of the metabolism 
of 7-benzyloxy-trifluoromethylcoumarin, 7- benzyloxyquinoline and testosterone, three 
substrates of CYP3A4, using fluorometric assays (Hansen et al., 2008).  Another study 
showed that E. purpurea inhibited CYP 3A4 mediated metabolism in C-DNA baculovirus 
which expressed human CYP 3A4 supersomes based on the decreased formation of 
6-OH-testosterone (Hellum et al., 2008).  Several Echinacea ethanolic extracts (11.2 - 
2447 µg/mL) have been shown to inhibit baculovirus expressed CYP 2C19, 2D6, and 3A4 
by 20-100 %, and alkamides contributed to the inhibitory effects seen with Echinacea 
preparations (Modarai et al., 2007).  The interaction between Echinacea and drugs has 
been investigated.  E. purpurea root extract (400 mg) significantly increased the systemic 
clearance of intravenous midazolam by 34% but reduced clearance of caffeine and 
tolbutamide in twelve healthy subjects, indicating the inhibition on CYP3A at hepatic and 
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intestinal sites as well as improving of CYP 1A2 and CYP 2C9 activity (Gorski et al., 2004).  
Therefore, alkamides in Echinacea extracts not only can be enzymatically metabolized, but 
also may contribute to the inhibition of of these same enzymes as shown by extracts from 
different Echinacea species. 
 
A previous study showed that n-hexane root extracts from E. pallida, E. angustifolia and E. 
purpurea at 30 µg/mL inhibited multidrug transporter P-glycoprotein (P-gp) activity in a 
human proximal tubular cell line (Romiti et al., 2008).  P-gp transporter plays a key role in 
drug absorption and distribution because it limits the permeability across the GI tract by 
active efflux of potentially toxic substances back into the intestinal lumen.  The 
transporter is also expressed in other tissues such as liver, kidney and blood–brain barrier 
where it also plays an important excretory role.  On the other hand, P-gp confers resistance 
to anticancer chemotherapy because it is over-expressed in cancer cells (O'Connor 2007).   
The use of botanicals which have anticancer properties as ABC transporter inhibitors may 
allow a new paradigm of clinically useful drug resistance circumvention. 
 
In summary, it is crucial to investigate the uptake and metabolism of key components found 
in various Echinacea species as well as the influences of Echinacea plant matrix on the 
bioavailability of these key constituents.  Because Echinacea supplements are usually 
ingested on a chronic basis, their long term effects on metabolic enzymes and efflux 
transporters needs to be investigated and may be of importance regarding herb–drug 
interactions. 
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3. OVERALL INTRODUCTION OF PRUNELLA VULGARIS 
Prunella vulgaris, a perennial herb known as self-heal, is widely distributed throughout 
Asia and Europe, is used primarily as a traditional botanical medicine to reduce 
osteoarthritis, rheumatoid arthritis, and gingivitis (Song et al., 2007; Adámková et al., 2004; 
Jung et al., 2001). In China, P. vulgaris is called ‘Xia Ku Cao’ and has a long history in 
therapeutic use as an antipyretic, and more recently for anti-keratitis purposes (Zheng et al., 
1990).   In Turkey, P. vulgaris is used primarily as an expectorant, tonic, antidiarrhoeic, 
against dysentery, for common cold, rheumatoid arthritis and cardiac arrhythmia (Pinkas et 
al., 1994; Markova et al., 1997).  More recently, increasing evidence suggests that organic 
preparations of P. vulgaris exhibited anti-estrogenic, anti-inflammatory, and antioxidative 
properties in vitro cell models and in rats (Psotova et al., 2003).  
 
3.1 Phytochemistry of Prunella vulgaris 
It has been found that aqueous extract of P. vulgaris contains on an average alkaloid (1.1%), 
saponins (0.4%), phenolic acids (0.06%), tannins (0.06%), carbohydrates (0.4%), proteins 
(0.4%) and lipids (2.4%, Rasool et al., 2010).  The amount of caffeic acid, chlorogenic 
acid and rosmarinic acid (Figure 2) in P. vulgaris was about 0.29, 0.32, and 9.46 mg/g, 
respectively, in dried plant (Sahin et al., 2011).  Cheung and Zhang (2008) reported that 
the concentration range of oleanolic acid, ursolic acid, and betulinic acid (Figure 2) was 
0.3-0.9, 1.5-4.0, and 4.7-5.5 mg/g, respectively, in P. vulgaris samples collected from 
different areas of China.  Rutin, quercetin, hyperoside, isoquercitrin, luteolin, cinaroside, 
kaempferol, and kaempferol-3-O- glucoside, etc (Figure 2) were identified from the 
methanol extract of P. vulgaris and the total amount of flavonoids was in the range of 
2.16-10.29 % (Liao et al., 2008).   
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Figure 2. Phenolic acids, flavonoids, and triterpenoids in Prunella vulgaris 
3.2 Health benefits of Prunella vulgaris 
3.2.1 Anti-oxidant effects 
P. vulgaris ethanol extract, containing 6.1% of major hydroxycinnamic acids, showed 
significant anti-oxidative activities in terms of free radical scavenger effect on DPPH and 
the anti-oxidative activity was partly in relation to the content of rosmarinic acid in this 
plant (Lamaison et al., 1991).  The aqueous extracts of P. vulgaris inhibited rat erythrocyte 
hemolysis by 81 % and lipid peroxidation by 95% in rat kidney and brain homogenates at 
200 µg/mL, as well as demonstrated strong superoxide- and hydroxyl radical-scavenging 
activity by 61% at 100 µg/mL, but the content of the major constituents of P. vulgaris was 
not determined in this study (Liu and NG, 2000). 
 
3.2.2 Anti-inflammatory effects 
Ethanol extracts of P. vulgaris at 30 µg/mL, rather than water extracts, significantly 
inhibited production of LPS-induced inflammatory mediators PGE2 and NO by RAW 
264.7 mouse macrophages (Huang et al., 2009).  In this study, rosmarinic acid in P. 
vulgaris extract at 2.67 µM was found to independently inhibit inflammatory response, but 
it only partially explained the extract’s activity.  LPS-induced cyclooxyginase-2 (COX-2) 
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and nitric oxide synthase (iNOS) protein expression were both attenuated by P. vulgaris 
ethanol extracts, while rosmarinic acid only inhibited COX-2 expression.  These authors 
suggest that the inhibition exists at the transcriptional level and there could be compounds 
other than rosmarinic acid in the extracts inhibiting the expression and/or the activity of the 
two critical enzymes in inflammation.   
 
The anti-allergic and anti-inflammatory constituents in P. vulgaris have been identified to 
be triterpenes such as betulinic acid, ursolic acid, 2α, 3α-dihydroxy -ursoic acid, and 
2α-hydroxyursolic acid.  2α, 3α-Dihydroxyursolic acid exhibited significant inhibition on 
the release of β-hexosaminidase, a marker molecule for examining the degranulation 
process in RBL-2H3 mast cells, in a dose-dependent manner and the IC50 value was 57 µM.  
Ursolic acid and 2α-hydroxyursolic acid exhibited strong inhibition on the production of 
NO from RAW 264.7 cells and the IC50 was 17 and 27 µM, respectively (Ryu et al., 2000).  
Therefore, major constituents contained in P. vulgaris contribute to the anti-inflammatory 
activities and NF-κB activation and COX-2 inhibtion might be the underlying mechanism. 
 
3.2.3 Anti-mutagenic effect 
Several triterpenoids including oleanic acid, 2α, 3α, 19α-trihydroxyursolic acid, and 
maslinic acid inhibited A549 (non small cell lung adenocarcinoma), SK-OV-3 (ovarian 
cancer cells), SK-MEL-2 (skin melanoma), and HCT15 (colon cancer cells), using the 
sulforhodamin B bioassay to test the cytotoxicity, with the ED50 range between 3.7 -28 µM 
(Lee et al., 2008).  A water extracts of P. vulgaris at 50 µg/mL had a moderate 
antimutagenic activity against picrolonic acid and benzo[a]pyrene induced mutation using 
the Salmonella/microsomal system (Lee and Lin, 1988).  Polysaccharide P32 (5 and 10 
g/kg) isolated from P.vulgaris extract, consisted of rhamnose, arabinose, xylose, mannose, 
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glucose and galactose in a molar ratio of 3.46:49.32:58.91:0.43:2.64: 3.11, decreased the 
number of tumors and weight by 64% and 55%, respectively, and significantly increased 
the relative thymus weight to the body weight by 1.4 fold and the relative spleen weight to 
the body weight by 1.3 fold in tumor-bearing mice (p < 0.05), indicating anti-tumor and 
immunomodulation effects (Feng et al., 2010).  In addition, the protective activity of 
rosmarinic acid from Perilla frutescens on liver injury induced by LPS in 
D-GalN-sensitized mice was examined (Osakabe et al., 2002).  In this study, Perilla 
extract (PE, 50-200 mg/kg in feed) and rosmarinic acid (135 mg/kg in feed) treatments 
significantly reduced the elevation of plasma asparatate aminotransferase levels by 75%,  
but PE and rosmarinic acid treatments did not significantly diminish iNOS mRNA 
expression or plasma nitrate/nitrite levels as well as TNF-α mRNA expression both in liver 
and plasma, indicating that liver protection of RA is due to the scavenging or reducing 
activities-superoxide or peroxynitirite rather than to inhibition of TNF-α production.  
Therefore, rosmarinic acid, triterpenoids and polysaccharides are responsible for the 
overall anti-tumor activites of P. vulgaris and the immunomodulatory and anti-oxidative 
effects may contribute to the anti-adenocarcinoma activity. 
 
3.2.4 Anti-viral effects 
The anti-HIV activity of P. vulgaris was reported by Tabba et al. (1989).  The water 
extract of P. vulgaris (50 µg/mL) significantly inhibited HIV-1 replication by blocking cell 
to cell transmission of the virus, preventing syncytium formation, and interfering with the 
ability of the virus to bind to CD4 receptor, suggesting that P. vulgaris extract antagonized 
HIV-1 infection of susceptible cells by preventing viral attachment to the CD4 receptor 
(Tabba et al., 1989).  Moreover, anionic polysaccharides and triterpenoids from P. 
vulgaris had anti-HSV activity in vitro.  The antiviral activity (EC50) was about 66 µM, 20 
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µM and 10 µg/mL for betulinic acid, 2α, 3α-dihydroxyursolic acid and polysaccharides, 
respectively, measured by plaque reduction assay (Xu et al., 1999).  In summary, studies 
have shown that P. vulgaris possesses a variety of pharmacological properties, and these 
novel properties may be utilized for future potential therapeutic applications.   
 
3.3 Bioavailability of Prunella vulgaris chemical constituents 
Most of the published papers were focusing on the bioavailability and pharmacokinetics of 
caffeic acid derivatives, triterpenoids, and flavonoids in P. vulgaris in human and cell 
culture models.  Konishi and Kobayashi (2005) investigated transepithelial transport of 
rosmarinic acid, the major bioactive constituent in P. vulgaris, in intestinal Caco-2 cell 
monolayers and found that rosmarinic acid transferred across the intestinal barrier mostly 
by paracellular diffusion, like other esterified phenoclic acids, i.e. chlorogenic acid.  The 
apparent permeability coefficient, Papp, for rosmarinic acid in Salvia miltiorrhiza ethanolic 
extract was 0.523 ± 0.301 × 10-6 cm/s (Lu et al., 2008).  The effects of pH and the direction 
of permeation on the absorption of phenolic acids in Caco-2 cell system have been 
investigated, i.e. caffeic acid exhibited a pH-dependent directional transport from the apical 
to the basolateral side (Konishi et al., 2004).  However, Lu et al. (2008) showed that there 
was no significant difference between Papp of apical to basolateral and basolateral to apical 
side for rosmarinic acid, a caffeic acid derivative.  Meanwhile, the permeation of 
rosmarinic acid from the apical to the basolateral side in the presence of a proton gradient 
(pH gradient 6.0/7.4) was nearly the same as that in the absence of a proton gradient (pH 
gradient 7.4/7.4), implying that proton coupled polarized transport was not involved for 
rosmarinic acid.  In in vivo studies, Jirovsky et al. (2007) showed that after 91 days of 
feeding in pigs with methanol extract of P. vulgaris, rosmarinic acid and its metabolites 
were found in plasma at >0.08 μM after the hydrolysis by β-glucuronidase/arylsulfatase to 
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release the parent compound.  Taken together, intact rosmarinic acid is poorly absorbed in 
the small intestine. 
 
The uptake of triterpenoids such as oleanolic acid and betulinic acid has been studied both 
in vitro and in vivo.  Papp value of oleanolic acid in Caco-2 cells was 1.1–1.3 × 10-6 cm/s.  
The absolute oral bioavailability was 0.7% for oral doses of 25 and 50 mg/kg of oleanolic 
acid in rats, indicating that oleanolic acid is also poorly absorbed and might be extensively 
metabolized in vivo (Jeong et al., 2007).  The uptake kinetics of 2,3-hydroxybetulinic acid 
in Caco-2 cells followed a one-phase exponential association process, reached near 
saturation after approximately 60 min and a maximal intracellular concentration of about 
906.7 uM/mg protein, indicating the facilitated absorption of this particular compound 
(Zheng et al., 2007). 
 
The absorption of flavonoids has been studied.  Walgren et al. (1998) found out that the 
reverse basolateral to apical flux of quercetin (Papp 11.1 ± 1.2 x 10-6 cm/s) was almost 2-fold 
higher than the apical to basolateral flux (p < 0.001).  Quercetin 4-glucoside demonstrated 
no absorption but did demonstrate basal to apical flux (Papp 1.6 ± 0.2 x 10-6 cm/s).  
Quercetin-3, 4'-diglucoside showed a low apical to basolateral transport (Papp 0.09 ± 0.03 x 
10-6 cm/s) and its reverse, basolateral to apical, transport was, however, 4-fold higher (p < 
0.05).  These results suggest that facilitated absorption of quercetin through the human 
intestinal epithelium might be involved.  Wang et al. (2005) also reported that quercetin, 
kaempferol and isorhamnetin displayed polarized transport, with the Papp, 
basolateral-apical being higher than the Papp apical-basolateral in Caco-2 cells.  
Meanwhile, quercetin and kaempferol (50 µM for each) inhibited the ATPase activity, and 
isorhamnetin (50 µM) stimulated the ATPase activity (p < 0.05) and the concentrations of 
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these flavonoids were significantly increased when incubated with the P-gp inhibitor 
verapamil (p < 0.05).  The results indicated that quercetin, kaempferol and isorhamnetin 
were substrates of P-gp and the P-gp type efflux pump might limit the bioavailability of 
these flavonoids.   
 
3.4 Metabolism of Prunella vulgaris 
A major limiting step in the utilization of bioactive compounds from P. vulgaris is their 
intestinal absorption and metabolism.  Phase I and II metabolites are often, but not always, 
less bioactive than parent compounds.  The absorption or metabolism of rosmarinic acid 
has been examined in vivo to a limited extent (Baba et al., 2004; Konishi et al., 2005; Baba 
et al., 2005).  When Perilla extract containing 200 mg of rosmarinic acid was orally 
administered to six men, rosmarinic acid in both plasma and urine was present 
predominantly as glucuronide and/or sulfate conjugated forms, at 0.6 ± 0.2% and 1.5 ± 0.4% 
of the total intake, respectively, within 48 h after ingestion (Baba et al., 2005).  Rosmarinic 
acid (1.5%), methylated rosmarinic acid (2.9%), caffeic acid (1.0%), ferulic acid (1.0%) 
and a trace of m-coumaric acid (0.02%) were detected in the urine after 48 h intake of the 
plant extract (Baba et al., 2004).  Therefore, ingested rosmarinic acid was absorbed and 
metabolized into conjugated and/or methylated forms and degraded to other caffeic acid 
derivatives.   
 
Gut microbes may metabolize rosmarinic acid to give phenolics such as caffeic acid, 
o-coumaric acid, 3, 4-dihydroxyphenylpropionic acid (DHPP) and 
m-hydroxyphenylpropionic acid (mHPP), in which m-coumaric acid and mHPP were 
absorbed by monocarboxylic acid transporter (MCT)-mediated active processes, whereas 
23 
   
DHPP was mainly permeated across Caco-2 cells via the paracellular pathway (Konishi 
and Kobayashi, 2005).  
 
The metabolism of the flavonoids has been investigated both in vitro and in vivo.  
Quercetin was metabolized to several substances in human leukaemia (HL-60) cells, such 
as quercetin glucuronides, quercetin-sulfate, myricetin by hydroxylation, isorhamnetin by 
methylation, and quinone form via oxidation (Ludwig-Müller et al., 2005).  Another study 
investigated the effect of quercetin and its metabolites on paraoxonase 2 levels in 
RAW264.7 macrophages (Boesch-Saadatmandi et al., 2009).  Intracellular antioxidant 
enzyme paraoxonase 2 (PON2) may have a protective function in the prevention of 
atherogenesis.  An enhancement of PON2 activity by dietary factors including flavonoids 
is therefore of interest.  In this study, supplementation of RAW264.7 macrophages in 
culture with quercetin at 1, 10, and 20 µM resulted in a significant increase in PON2 
mRNA and protein levels, as compared to untreated controls.  Unlike quercetin, its 
glucuronidated metabolite quercetin-3-glucuronide did not affect PON2 gene expression in 
cultured macrophages.  However the methylated quercetin derivative isorhamnetin 
enhanced PON2 gene expression in RAW264.7 cells to a similar extent as quercetin.  
These results indicate that circulating flavonoid metabolites possess biological properties 
different from their nonconjugated parent compounds, further proving the importance of 
understanding the metabolic fate of the bioactive constituents via Phase I and II 
biotransformation as well as gut microbial metabolism. 
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4. OVERALL INTRODUCTION OF CAFFEIC ACID DERIVATIVES 
4.1 Source and intake of caffeic acid derivatives  
Caffeic acid (3, 4-dihydroxycinnamic acid), one of the most common phenolic acids, 
frequently occuring in fruits, vegetables, grains, dietary supplements and traditional herbs 
as simple esters with quinic acid or saccharides (caffeic acid derivatives).  Caffeic acid is 
the main phenolic acid aglycone in potatoes, with contents varying from 0.3 to 3.6 mg/100 
g and 18.8 to 28 mg/100 g in tubers and peels, respectively (Radtke et al., 1998).  
Chlorogenic acid is an ester of caffeic and quinic acids in coffee and many types of fruits, 
coffee, tea and traditional herbs (Clifford, 1999).  Coffee consumers ingest 0.5-1 g 
chlorogenic acid/d (Clifford et al., 1999).  In another study, caffeic acid intake was found 
to be 206 mg/d, and the principal sources were coffee (92% of caffeic acid) and fruit and 
fruit juices combined (Radtke et al., 1998).  Indeed, coffee consumption was shown to be 
positively correlated to caffeic acid and chlorogenic acid intake, indicating that they can be 
used as biomarkers for the estimation of dietary intake (Mennen et al., 2006).  
 
Rosmarinic acid is a caffeic acid derivative found in many Lamiaceae herbs used 
commonly as culinary herbs such as lemon balm, rosemary, oregano, sage, thyme and 
peppermint (Lamaison et al., 1991).  The first plant cell cultures found to be accumulating 
rosmarinic acid were derived from Coleus blumei (Razzaque and Ellis, 1977).  Suspension 
cultures from this species were the first ones used for an attempted biotechnological 
production of rosmarinic acid since they were found to accumulate up to 21% rosmarinic 
acid in the dry weight.  Basil, lemon thyme, mint, oregano, rosemary, sage, and thyme 
were investigated to contain 0.22-0.97% of rosmarinic acid (Park, 2011).   
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Caffeic acid derivatives were metabolized by both human and animal gut microbes.  
Rosmarinic acid (Konishi and Kobayashi, 2005; Yoshikawa et al., 2005), chlorogenic acid 
(Konishi and Kobayashi, 2005), and cichoric acid (Peppercorn et al., 1971) were cleaved 
by microbial esterase, hydrolyzed to caffeic acid and then reduced to dihydrocaffeic acid (3, 
4dihydroxyphenylpropionic acid); furthermore the later was dehydroxylated to 
m-hydroxyphenylpropionic acid (mHPP).  After administration of chlorogenic acid at 250 
μmol/day in rats for 8 days, total urinary excretion of caffeic, ferulic, and isoferulic acids 
was 28.1 % of intake (mol/mol); urinary mHPP was 4.0 %.  Plasma metabolite 
concentrations in rats fed caffeic acid (250 μmol/day) for 8 d were caffeic acid (41.3 μM), 
ferulic acid (7.3 μM), isoferulic acid (4.5 μM), hippuric acid (54.2 μM), and mHPP (1.4 μM) 
(Gonthier et al., 2003).  When Perilla extract containing 200 mg of rosmarinic acid (RA) 
was orally administered to six men, RA in both plasma and urine was present 
predominantly as glucuronide and/or sulfate conjugated forms, at 0.6 ± 0.2% and 1.5 ± 0.4% 
of the total intake, respectively, within 48 h after ingestion (Baba et al., 2005).  Gut 
microbes metabolized RA to give phenolics such as caffeic acid, o-coumaric acid and 
m-hydroxyphenylpropionic acid, which are then absorbed by monocarboxylic acid 
transporter (MCT)-mediated active processes (Konishi and Kobayashi, 2005). In summary, 
caffeic acid derivatives are ingested by humans and metabolized to various metabolites, 
which may contribute to the health benefits. 
 
4.2 Anti-inflammatory activities of caffeic acid derivatives  
Caffeic acid phenethyl ester, at 25μg/mL, has been shown to suppress NF-κB activation by 
suppressing the binding of the p50-p65 complex directly to DNA in human histiocytic 
U937 cells (Natarajan et al., 1996).  Nuclear factor kappa-B (NF-κB) was a heterodimeric 
transcription factor with a pivotal role in orchestrating immune and inflammatory 
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processes.  In this study, the activation of NF-κB by TNF-α was completely blocked by 
caffeic acid phenethyl ester in human histiocytic cell line U937 cells, which are used to 
study the behaviour and differentiation of monocytes (Natarajan et al., 1996).  In another 
study, caffeic acid and the predominant isomer of chlorogenic acid, 5-caffeoylquinic acid, 
significantly inhibited the H2O2 or TNF-α induced interleukin (IL-8) secretion and its 
mRNA expression in a dose-dependent manner in the range of 0.25-2.00 mM in Caco-2 
cells (Zhao et al., 2008).  IL-8 is a central pro-inflammatory chemokine involved in the 
pathogenesis of IBD.   
 
Chlorogenic acid (5-20 μM) also showed suppression of IL-1β-induced activation of 
NF-κB, degradation of inhibitor of κB (IκB)-α, as well as matrix metalloproteinases 
(MMP-1, MMP-3, MMP-13) expressions in chondrocytes isolated from rabbits (Chen et al., 
2011).  IL-1β is a pivotal catabolic factor in inflammatory cascades and induces 
inflammatory mediators and MMPs, leading to disruption of the balance between 
biosynthesis and degradation of the extracellular matrix (Chen et al., 2011).  Chlorogenic 
acid (50 mg/kg, intraperitoneally) suppressed hepatic mRNA expression of toll-like 
receptor 4 (TLR4), TNF-α and phosphorylation of NF-κB p65 subunit in LPS-induced liver 
injury in mice (Xu et al., 2010).  TLR4, one of the members of the TLR protein family, is 
essential for LPS-mediated signaling.  After binding to TLR4 and CD14, LPS triggers 
several critical intracellular signaling pathways, including NF-κB signaling cascade, and 
leads to the production of inflammatory cytokines including TNF-α, INF-γ and nitric oxide 
(Takeuchi et al., 1999). 
 
Rosmarinic acid, at 1μM, reduced serum levels of TNF-a, IL-6, high-mobility group box 1 
protein, while increased serum level of IL-10 in rats induced by cecal ligation and puncture.  
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Amelioration of hemodynamics and decrease in myeloperoxidase in lung, liver, and small 
intestine were also observed after rosmarinic acid injection (Jiang et al., 2009).  In another 
study, rosmarinic acid in P. vulgaris (2.67 µM) was found to independently inhibit 
LPS-induced inflammatory mediators PGE2 and NO by RAW 264.7 mouse macrophages, 
via COX-2 inhibition (Huang et al., 2009).  These results suggest that caffeic acid 
derivatives, including caffeic acid, chlorogenic acid and rosmarinic acid, have the capacity 
to inactivate inflammatory response and the anti-inflammatory mechanism may inhibit 
activation of the NF-κB pathway by inhibiting IκB kinase activity. 
  
5. INTESTINAL ABSORPTION, METABOLISM, INFLAMMATORY 
RESPONSES, AND RELEVANT METHODOLOGY 
5.1 Intestinal function   
5.1.1 Absorption mechanisms 
Dietary bioactive compounds pass across the intestinal epithelium via passive and active 
mechanisms.  In passive transport, the cells do not use any energy to move the molecules 
and the molecules move through the concentration gradient (higher concentration to lower 
concentration).  Passive diffusion can be divided into either transcellular diffusion 
(through the cells) or paracellular diffusion (intercellular spaces).  Transcellular passage 
includes the partition between the aqueous contents of intestinal lumen, the phospholipid 
bilayer of the apical cell membranes, the aqueous contents of the enterocytes, and again, the 
phospholipid bilayer of the basolateral cell membranes (Borchardt, 1998).  The compound 
via paracellular pathway is usually polar or hydrophilic and small (Hidalgo, 1996) and the 
transcellular pathway is more common route, since the cellular absorbing surface is over 
1000 times greater than the area of the paracellular spaces (Pappenheimer and Reiss, 1987).  
The chemical and physical properties of the compound are critical for the permeability 
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across the epithelial cells.  For example, chlorogenic acid and rosmarinic acid are 
considered to pass across the epithelial barrier via paracellular pathway, while alkamides 
transport via transcellular pathway (Konishi and Kobayashi, 2005; Matthias et al., 2005; 
Konishi and Kobayashi, 2004).  Moreover, caffeic acid conjugates (caftaric acid, cichoric 
acid and echinacoside) were not detected in any plasma sample at any time after ingestion 
of Echinacea ethanolic extract, whereas alkamides were in the range of 0.1-120 ng/mL in 
plasma 20 minutes after ingestion (Matthias et al., 2004), which might be because that 
alkamides are more hydrophobic than caffeic acid derivatives, thus more bioavailable.  
 
Membrane transporters located in the cell membranes are responsible for active transport 
of nutrients.  Active transport is the energy-demanding transfer of a nutrient across a cell 
membrane against its concentration gradient (lower concentration to higher concentration, 
Gropper et al., 2008).  The energy for active transport comes from ATP generated by 
respiration (in mitochondria).  The active transport can be classified into facilitated 
diffusion, primary active and secondary active transport, based on the energy requirement 
(Amidon and Sadée, 1999).  Facilitated diffusion does not require energy for its function 
and specific molecules move down a concentration gradient, passing through the 
membrane via a specific carrier protein.  Thus, rather like enzymes, each carrier has its 
own shape and only allows one molecule (or one group of closely related molecules) to 
pass through.  Primary active transport is an energy demanding process and the energy is 
gained from hydrolysis of ATP to ADP from the high-energy phosphate bond.  Secondary 
active transport uses energy from ion gradients (mostly Ca2+, Na+, and H+ -gradients) 
across the cell membranes generated by primary active ion pumps (for example 
Na+/K+-ATPase), and are also called symporters or antiporters (Amidon and Sadée, 1999).  
Characteristics for active transport are the saturability of the carrier protein and 
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temperature dependency.  Several absorptive transport systems with the primary function 
of transporting nutrients (amino acids, oligopeptides, monocarboxylic acids, 
monosaccharides, organic anions and cations, bile acids and several water soluble vitamins) 
are present in the small intestine (Steffansen et al. 2004).  Caffeic acid and its colonic 
microbial metabolites, such as o-coumaric acid , ferulic acid and 
m-hydroxyphenylpropionic acid (mHPP) transport across the intestinal epithelial cells via 
monocarboxylic acid transporter (MCT, Konishi and Kobayashi, 2004), indicating that a 
monoanionic carboxyl group and a non-polar side chain or aromatic hydrophobic moiety 
are thought to be necessary components of a substrate for MCTs.  Moreover, the major 
intestinal glucose transporters, such as Na+-dependent glucose transporter SGLT1 
(SLC5A1), the facilitative transporter GLUT2 (SLC2A2), and GLUT4 (SLC2A4), have 
been regarded as specific carriers for the transport of some flavonoids, such as quercetin, 
quercetin glycosides, myricetin, catechin-gallate, and genistein (Chen et al., 2007; Strobel, 
et al., 2005).  Therefore, the membrane transfer of phytochemicals is a fundamental part of 
their bioavailability, and the uptake mechanisms of phytochemicals could be 
compound-specific, which depends on the compound structure and conjugated moieties. 
 
5.1.2 Metabolism 
Although the human small intestine serves primarily as an absorptive organ, it also has the 
ability to metabolize nutrients, drugs and other molecules.  Many of the enzymes involved 
in Phase I and II reactions in the human liver have also been detected within intestinal 
epithelial cells.  Cytochrome P450 (CYP) enzymes are located at the villous tip just 
beneath the brush border at the apex of the enterocyte, the main site of absorption for orally 
administered compounds and CYP content in human small intestine ranges from 20 to 210 
pmol/mg, implying that significant variability in intestinal CYP expression: total CYP 
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content slightly increases from the duodenum to the jejunum and then decreases toward the 
ileum (Thelen and Dressman, 2009).  The goblet cells and the epithelial cells of the crypts 
between the villi contain lower levels of drug metabolizing enzymes.  As mentioned 
before, alkamides can be metabolized by CYPs to form epoxides, and N-dealkylated and 
hydroxylated products (Matthias et al., 2004).  The most active hepatic CYP isoforms 
involved in the production of epoxides were CYP1A1, CYP1A2 and CYP2A13, whereas 
for the N-dealkylation only CYP1A1, CYP1A2 and CYP1B1 showed significant activity.  
Of these forms CYP 1A1 was detected in human intestinal samples, although at least at low 
levels (3.6–7.7 pmol/mg) while CYP1A2, is an almost exclusively hepatic CYP enzyme, 
being virtually undetectable in human small intestine (Paine et al., 2006; Shimadat et al., 
1994).  More interestingly, the 2, 4-diene alkylamides were more rapidly metabolized 
when examined as the pure compound rather than in the Echinacea extract, suggesting that 
some of the other consistuents present in the extract might have exerted an inhibitory effect 
towards their metabolism by CYPs.   
 
Among Phase II enzymes, UDP-glucuronosyltransferase (UGT) and sulfotransferase 
(SULT), which catalyze sulfation and glucuronidation, may play important roles in the 
conjugation and ultimately excretion and elimination of many phytochemicals containing 
hydroxyl functional group either present in the parent structure and/or after 
biotransformation by the phase I enzyme such as the CYPs (Rushmore and Kong, 2002).  
Some flavonoids, such as baicalein, quercetin, and methylated quercetin, are substrates of 
UGT1A3 and UGT 1A9 and the preferred substrates for UGT1A3 and UGT1A9 contain 
the hydroxyl group at the C7-position (Xie et al., 2010).  Moreover, luteolin in Artemisia 
afra aqueous extract, regardless of its form (i.e. whether aglycone and 7-0-glucoside), was 
taken up better and more efficiently metabolized to luteolin monoglucuronide, sulfate and 
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methylated luteolin sulfate conjugates than the aglycone and 7-0-glucoside forms 
administered as pure solutions in Caco-2 cells (Mukinda et al., 2010), implying the 
necessity to investigate the effect of the plant matrix on the uptake and metabolism of 
phytochemicals. 
 
Therefore, the small intestine plays a key role in first-pass metabolism of orally ingested 
phytochemicals, which is supported by the position of the small intestine as the first site of 
exposure of phytochemicals to metabolic systems, by the large surface area available in the 
small intestine for absorption and subsequent metabolism, and by the transpoters located 
both at apical and basolateral sides of the enterocytes involved in the transfer or efflux of 
the substrates. 
 
Transporters, such as P-glycoprotein (P-gp), multidrug resistance-associated protein 
(MRP), and organic anion transporting polypeptide (OATP) are expressed in intestine, 
where they provide a formidable barrier against drug penetration, and play crucial roles in 
drug absorption, distribution, and excretion (Xu et al., 2005, Figure 3).  Because P-gp and 
MRP utilize ATP to transport substrate the cell membrane, they are called ATP binding 
cassette (ABC) transporters, which import or export a broad range of substrates, such as 
amino acids, ions, sugars, lipids, etc.  In human, 46 ABC transporters have been identified 
(Chang, 2003).  All ABC transporters are composed of two nucleotide binding domains 
(NBDs) and two transmembrane domains (TMDs).  The role of TMD is to recognize and 
mediate the passage of substrates across the cell membrane (Chang, 2003).  First-pass 
metabolism can be affected by the interaction between CYP isoforms, specifically CYP 
3A4, and P-gp in enterocytes (Patel and Mitra, 2001, Figure 3).  Since CYP3A4 and P-gp 
are both localized to mature enterocytes on the villus tip, the extensive overlap among the 
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substrates for P-gp and CYP3A4, and pregnane X receptor (PXR) mediates co-induction of 
CYP3A4 and P-glycoprotein, thus P-gp and CYP3A4 could be coordinately regulated, and 
substrate for both P-gp and CYP3A4 may be absorbed directly into the systemic circulation, 
metabolized by CYP3A4 in the enterocyte or secreted back into the intestinal lumen by 
P-gp (Patel and Mitra, 2001).  Therefore, P-gp-mediated efflux and CYP3A4 metabolism 
may be functionally interrelated and act accordingly to limit the passage of the molecules 
across the enterocyte.    
 
However, some flavonoids, such as quercetin (Scambia et al., 1994), myricetin (Choi et al., 
2010) and genistein (Sergent et al., 2009) have been shown to inhibit P-gp-mediated efflux 
and CYP3A4 both in Caco-2 cells and animal models.  These results underline the 
importance of intestinal studies to assess transporter activity linked to the ingestion of 
phytochemical- enriched supplements. 
 
 
Figure 3. Transporters in intestinal epithelial cells 
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Note: BCRP: breast cancer resistance protein ; LRP: lung resistance-related protein; MRP: 
multidrug resistance- associated protein; P-gp: P-glycoprotein; MCT: monocarboxylic acid 
transporter; hPepT1: human peptide transporter 1.  
 
5.2 Inflammatory responses of the intestine 
Besides the absorptive and metabolic capabilities, the intestine mucosa membrane 
exercises a truly antitoxic and protective function with regard to the microbial poisons.  
Changes to this mucosal barrier can affect the absorption of both exogenous and 
endogenous nutrients.  Many diseases, such as inflammatory bowel disease (IBD), 
ischemic disease, and graft-versus-host disease, are associated with the loss of intestinal 
mucosal barrier function (Clayburgh et al., 2004; Chen et al., 2003; Hill et al., 2000).  
Therefore, an intact intestinal mucosal barrier is of great importance for both ensuring 
adequate provision of dietary nutrients to the whole body and preventing gut-related 
diseases. 
 
An intact mucosal barrier depends on intercellular junctions, which help to seal the space 
between adjacent epithelial cells (the paracellular space), and tight junctions, which are the 
key elements of the seal (Turner, 2006).  Tight junctions play a key role in the intestinal 
physical barrier to the diffusion of pathogens, toxins, and allergens from the lumen into the 
circulatory system.  Tight junctions are multi-protein complexes composed of 
transmembrane proteins (i.e. occludin, claudins and junctional adhesion molecule (JAM)), 
peripheral membrane (scaffolding) proteins (i.e. zonula occludens (ZO)), and regulatory 
molecules that include kinases (Figure 4).   
The most important of the transmembrane proteins are members of the claudin family, 
which not only define tight junction permeability and affect barrier function, but also 
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enhance cell proliferation and regeneration, as might be necessary to compensate for cell 
loss in colitis.  For example, increased claudin-1 and claudin-2 expression has been 
reported in intestinal epithelial cells of patients with IBD (Heller et al., 2005).  Meanwhile, 
claudin-1 has also been shown to enhance neoplastic transformation, tumor growth and 
metastasis in experimental models (Dhawan et al., 2005).  Weber et al. (2008) reported 
that claudin-1 and claudin-2 expression was elevated in active IBD, adenomas, and 
IBD-associated dysplasia, but not acute, self-limited colitis (ASLC).  In contrast, 
claudin-4 expression was elevated in both active IBD and ASLC.  Thus, increased claudin 
expression may contribute to carcinogenesis in IBD. 
At least two routes allow transport across the tight junction: leaky pathway, which allows 
paracellular transport of large solutes, such as limited flux of proteins and bacterial LPS, 
and small pore pathway that is defined by tight junction-associated claudin proteins, which 
are primary determinants of charge selectivity and exclude molecules larger than 4 Å 
(Turner et al., 2009).  Thus, tight junctions show both size selectivity and charge 
selectivity, and these properties may be regulated individually or jointly by physiological 
or pathophysiological stimuli. 
 
Peripheral membrane proteins, such as ZO-1 and ZO-2, are crucial to tight junction 
assembly and maintenance, because recent work suggests that ZO-1, which interacts 
directly with actin, occludin, claudins and other proteins, may be an essential effector of 
perijunctional actomyosin ring-mediated tight junction regulation (Van et al., 2009).  In 
deed, Ca2+-calmodulin-dependent serine–threonine protein kinase myosin light chain 
kinase (MLCK), which phosphorylates myosin II regulatory light chain (MLC) within the 
perijunctional actomyosin ring to activate myosin ATPase activity, is essential for 
Na+-nutrient co-transport-induced tight junction regulation (Scharl et al., 2009).  Occludin, 
35 
   
a transmembrane tight junction protein also interacts directly with claudins and actin.  
However, although numerous in vitro studies demonstrated a role for occludin in tight 
junction function, occludin is an integral part of tight junction strands (Fujimoto, 1995), 
while not essential for strand assembly because intestinal barrier function is intact in 
occludin deficient embryonic stem cells and occludin-deficient mice (Saitou et al., 2000; 
Saitou et al., 1998).  
 
 
Figure 4. Intestinal epithelial intercellular junctions 
Note: ZO: zonula occludens 
In IBD, the paracellular space has increased permeability, and the regulation of tight 
junctions is defective (Wang et al., 2006; Bruewer et al., 2003).  The hallmark of active 
IBD is a pronounced infiltration into the lamina propria of innate immune cells (neutrophils, 
macrophages, dendritic cells, and natural killer T cells) and adaptive immune cells (B cells 
and T cells).  Increased numbers and activation of these cells in the intestinal mucosa 
elevate local levels of tumor necrosis factor α (TNF-α), interleukin-1β (IL-1β), interferon-γ 
(IFN-γ), and cytokines of the interleukin-23–T helper 17 pathway (Abraham and Cho, 
2009).  For example, in Crohn’s disease, there is increased production of the Th17 
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cytokine interleukin-17 and the Th1 cytokines interferon-γ and TNF-α in the intestinal 
mucosa.  In ulcerative colitis, by contrast, there is usually an increase in interleukin-17 and 
Th2 cytokines, such as IL-4, 5 and 13 (Abraham and Cho, 2009).   
 
The ability of cytokines, such as TNF-α and IFN-γ, to regulate the function of the tight 
junction barrier was first described 20 years ago (Madara et al., 1989).  Myosin light chain 
kinase (MLCK) has been shown to have a central role in TNF-α induced epithelial and 
endothelial barrier dysregulation.  Similar to Na+-nutrient co-transport, TNF-α-induced 
MLCK activation seems to increase paracellular flux through the leak pathway.  
IFN-γ-induced occludin internalization is mediated by myosin ATPase-dependent 
macropinocytosis and occludin cleavage may even modify the barrier to enhance 
transepithelial migration of inflammatory cells in the lung (Chun et al, 2009).  Moreover, 
IL-1β levels are markedly elevated in intestinal tissues in patients with IBD (Turner et al., 
2005).  Recent studies have shown that IL-1β at physiologically relevant concentrations 
(1-10 ng/ml) causes an increase in intestinal epithelial tight junction permeability, which is 
modulated in part by regulation of MLCK (Al-Sadi et al., 2007).  The IL-1β induced 
increase in Caco-2 tight junction permeability was preceded by an increase in MLCK 
mRNA and protein levels; and targeted inhibition of IL-1β induced MLCK mRNA or 
MLCK protein expression prevented the increase in tight junction permeability (Al-Sadi et 
al., 2008).  The IL-1β induced increase in retinal pigment epithelial tight junction 
permeability was associated with a down-regulation of occludin protein and increase in 
claudin-1 expression (Abe et al., 2003).  Other investigators have also shown that IL-1β 
causes an increase in claudin-1 and claudin-2 expressions and decrease in occludin 
expression in human astrocytes , Caco-2 cells and rat hepatocytes (Duffy et al., 2000; 
Yamamoto et al., 2004; Al-Sadi et al., 2008).  Therefore, in vitro research on intestinal 
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epithelial cells has mainly focused on the involvement of aforementioned cytokines- IL-1β, 
TNF-α and IFN-γ, which activate intracellular cascades, increase transcriptional activity 
and the secretion of other cytokines and chemokines, as well as increase the paracellular 
permeability though defects in tight junctioning or assembly. 
 
Therefore, it is critical to investigate the roles of the epithelial cell barrier in health and 
disease, with particular emphasis on the junctional complexes, which have a crucial role in 
barrier regulation.  Previous studies showed that some polyphenols, such as 
epigallocatechin gallate, genistein, myricetin, kaempferol and quercetin, enhance intestinal 
tight junctions in human intestinal Caco-2 monolayers (Wells et al., 1999; Suzuki and Hara, 
2010; Suzuki et al., 2011).  Caffeic acid phenethyl ester inhibited the down-regulation of 
occludin, a transmembrane tight junction protein, induced by TNF-α in astrocytes, possibly 
via NF-κB pathway because NF-κB could act as a negative regulator of occludin 
expression in astrocytes (Wachtel et al., 2001). But very few studies have investigated the 
influences of phenolic acids on gut barrier functions, which might be the underlying 
mechanism of the protective effects of caffeic acid derivatives against colitis or colon 
cancer in animal models (Ye, et al., 2009; Tanaka, et al., 1990; Feng et al., 2010).  Thus, 
our research will focus on the modulation of caffeic acid derivatives from traditional herbs 
on intestinal barrier function.  
 
5.3 Relevant methodology to study intestinal function 
It is important to determine the mechanism of the intestinal absorption of the ingested 
molecules and the interaction between the targeted compound and the intestinal epithelial 
cells, and hence it is vital to have good predictive models which offer information about the 
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fraction of compound absorbed across the intestinal wall, the amount of metabolism during 
absorption as well as the influence of the compound on the intestinal function.   
 
5.3.1 Caco-2 cells 
Caco-2 cell line was developed from a moderately well differentiated colon 
adenocarcinoma obtained from a 72-year-old male (Fogh et al. 1977).  Caco-2 cells 
differentiate spontaneously and exhibit structural and functional differentiation patterns 
characteristic of mature enterocytes (Pinto et al. 1983).  Caco-2 cells reach confluency 
within 4-6 days and reach fully differentiated status within 20 days (Pinto et al. 1983).  
The differentiated cells exhibit structural and functional differentiation patterns similar to 
mature human enterocytes, such as microvilli of the brush border membrane, tight 
intercellular junctions, and brush border associated enzymes, Phase I and II metabolizing 
enzymes as well as transporters.  The structural and functional differentiation of the 
microvilli is associated with the polarization of the monolayer after confluency. 
 
Some parameters, such as transepithelial electrical resistance (TEER) or transport of the 
hydrophilic molecule lucifer yellow or mannitol have been used as indicators of the 
epithelial integrity.  Caco-2 monolayers have a TEER between 250 and 800 Ω•cm2 which 
is similar to the TEER in the colon rather than that in the small intestine which is lower 
(Biganzoli et al., 1999).  Indeed, fully differentiated Caco-2 cells form an epithelial 
membrane with a barrier function similar to the human colon (Artursson et al., 1993) but 
express carrier proteins similar to the small intestine (Baker and Baker 1992; Hidalgo et al. 
1989).  An increase in the transport of hydrophilic paracellular marker indicates increases 
in the cell monolayer permeability (Hubatsch et al., 2007).  These parameters can be used 
to evaluate cytotoxicity of nutrients, drug and other compounds.   
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Bidirectional studies (apical to basolateral and basolateral to apical transport) in Caco-2 
cells enable the investigation of the mechanisms of passive paracellular and passive 
transcellular permeability, carrier mediated absorptive transport and efflux, as well as 
active transport (Artursson et al., 1993).  The apical compartment is used to mimic the 
intestinal lumen and the basal compartment mimicking the blood stream.   
 
Caco-2 cells express phase I (i.e. CYPs) and phase II detoxification enzymes (i.e. 
gluthathione S-transferase (GST), UGT and ST).  Because Caco-2 cells contain many of 
the metabolic enzymes found in the intestinal epithelium, they have been used to evaluate 
the metabolism of compounds during the transport across the intestinal barrier (Meunier et 
al., 1995).  Meanwhile, Caco-2 monolayers also express several absorptive and efflux 
transporters, such as P-gp, MRP, OATP, monocarboxylic transporter (MCT), breast cancer 
resistance protein transporter (BCRP), etc (Laitinen, 2006).  Thus the model can be useful 
to screen a large number of compounds liable to be substrates for the transporter, i.e. P-gp, 
and to define the role of the transporter in limiting the absorption of the applied 
compounds. 
 
Caco-2 cells also have limitations.  First, the high TEER due to the “tighter” monolayer 
compared with in vivo situation leads to very low permeability for hydrophilic, mostly 
paracellularly permeating compounds.  Caco-2 cells are better to study transcellularly 
passively permeating drugs (Laitinen, 2006).  Second, Caco-2 cells are a cancer-derived 
line and therefore may have properties different from normal cells.  Third, Caco-2 cells 
lack the crypt-villus axis, which is important for fluid and ion transport in vivo, and lack the 
mucus producing goblet cells, which leads to the lack of a prominent mucus layer 
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(Artursson 1996).  More recently, mixed cultures of Caco-2 cells with mucin-producing 
cells, i.e. HT-29, have been used in attempts to overcome this limitation of the method.  
 
In conclusion, the major advantage of cell culture models is that we don’t need to consider 
about the interspecies differences in the morphological and physiological characteristics, 
which are normal issues in animal models.  So the cell culture model (such as Caco-2) has 
been adopted enthusiastically by the pharmaceutical industry, for the screening of 
compounds for intestinal absorption.  It can provide comparative information, on the 
intestinal absorption, metabolism and the mucosal toxicity of applied molecules.  
Moreover, in vivo absorption studies performed with laboratory animals and humans are 
expensive and time consuming and can pose ethical challenge, thus cell model is a useful 
alternative to study uptake and transport of important compounds. 
 
5.3.2 Paracellular permeability test 
Paracellular permeability was measured by assessing transepithelial electrical resistance 
(TEER) and using the transfer of a paracellular marker, lucifer yellow (LY), across Caco-2 
monolayers (Hubatsch et al., 2007).   After 21 d post seeding the cells on the transwell, the 
transepithelial electrical resistance (TEER) was tested by Millicell ERS meter to reflect the 
tightness of intercellular junctions and only cells with TEER ≥ 250 Ω·cm2 were used for 
permeability study.   As mentioned before, Caco-2 monolayers have a TEER between 250 
and 800 Ω•cm2 which is similar to the TEER in the colon, and greater than that in the small 
intestine (Biganzoli et al., 1999).  The transfer of a paracellular transferred compound is 
correlated with the TEER change: the greater the TEER, the tighter the cell monolayer, the 
less transfer of the paracellularly transferred compound, i.e. rosmarinic acid and 
chlorogenic acid (Konishi and Kobayashi, 2004).  Further, the paracellular marker, LY 
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dissolved in Hank's Buffered Salt Solution was added to the apical chamber.  For LY 
quantification, the apical and basolateral solutions were collected after 1h, transferred to a 
96 well plate and read spectrophotometrically at 450 nm.  Previous studies used both 
TEER and LY transfer to investigate the enhancement of intestinal tight junctions in 
Caco-2 cells by some polyphenols, such as epigallocatechin gallate, genistein, myricetin, 
kaempferol and quercetin (Suzuki and Hara, 2010; Suzuki et al., 2011).  Therefore, TEER 
and LY are often used together to reflect the tightness of the monolayer and the paracelluar 
permeability.  
    
5.3.3 Western blot, immunofluorescence and ELISA 
Western blot is a widely used analytical technique for detecting specific proteins in the 
given sample of tissue homogenate or extract.  Gel electrophoresis was used first to 
separate denatured proteins by the size of the polypeptide.  The proteins were then 
transferred to a membrane (typically nitrocellulose or polyvinylidene fluoride, PVDF), 
where they were probed (detected) using antibodies specific to the target protein.  Tight 
junction protein expression has been studied extensively using Western blotting (Al-Sadi et 
al., 2008; Liu et al., 2010; Mukinda, et al., 2010; Suzuki et al., 2011).  Meanwhile, 
immunofluorescence uses the specificity of antibodies to their antigen to target fluorescent 
dyes to specific biomolecule targets within a cell, and therefore allows visualisation of the 
distribution of the target molecule through the sample.  Suzuki et al. (2009) and Amasheh 
et al. (2008) performed Western blot and immunofluorescence to measure the enhancement 
of intestinal barrier function by quercetin through the assembly of zonula occluden (ZO)-2, 
occludin, and claudin-1 and the expression of claudin-4 in Caco-2 cells.  Further, cytokine 
secretion, before and after treatment with stimuli to initiate the inflammatory response, was 
evaluated using a sandwich ELISA method and quantified using the standard provided with 
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the kit (Van De Walle et al., 2010).  Results were subsequently expressed in relative terms 
to the negative control (untreated cells) to facilitate comparison between groups.   
 
In conclusion, the overarching hypotheses in my study were that alkamides, ketones and 
caffeic acid derivatives were transferred by Caco-2 cell monolayers independent of plant 
matrix; and caffeic acid derivatives enhanced the intestinal barrier function.  We used 
Caco-2 cell with HPLC detection to investigate the permeabilities and Phase II 
biotransformation of botanical constituents, i.e. alkamides, ketones, rosmarinic acid and 
ursolic acid, as pure compounds and in plant extracts.  Western blot and 
immunofluorescence were used together to study the targeted tight junction protein 
expression and distribution, and ELISA was used to measure the cytokine excretion by 
Caco-2 cells with and without the stimuli treatment. 
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Abstract 
The use of Echinacea as a medicinal herb is prominent in the United States and many 
studies have been done over the years to assess the effectiveness of Echinacea as an 
immunomodulator. In this study, Bauer alkamides and ketones were hypothesized to be 
absorbed similarly as pure compounds or from Echinacea sanguinea and Echinacea pallid 
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ethanol extracts, as well as that these Echinacea extracts could inhibit P-glycoprotein 
transporter in Caco-2 human intestinal epithelial cells.  Using HPLC analysis, the order of 
the permeation rate of pure alkamides across Caco-2 cells was increased paralleled with 
compound hydrophicility with passive diffusion, independent of the plant matrix.  Tested 
alkamides were seemingly N-glucuronidated both as pure compounds and as found in two 
Echinacea species.  Both Echinacea ethanol extracts stimulated apparent glucuronidation 
and basolateral efflux of alkamide metabolites.  E. pallida ethanol extract inhibited the 
efflux of glucuronides of Bauer alkamide 8 and 11 apically (lumen) while inducing the 
transfer of the conjugates basolaterally (systemic).  Bauer ketone 24 was totally 
metabolized to more hydrophilic metabolites when administered as a pure compound, but 
not as found in either Echinacea extracts.  Bauer alkamide 8, 10 and 11 (175-230 µM) and 
E. sanguinea (1 mg/mL, containing 85 µM of alkamide 8, 2 µM of alkamide 10, and 0.7 
µM of alkamide 11) and E. pallida (5 mg/mL, containing 215 µM of alkamide 8, 25 µM of 
alkamide 10, and 45 µM of alkamide 11) ethanol extracts reduced the efflux of the 
P-glycoprotein transporter probe calcein-AM from Caco-2 cells.  These results suggest 
that other constituents in the plant extract had a facilitating effect on the metabolism and 
efflux of alkamides and ketones from Echinacea, which would improve the therapeutic 
benefits of these extracts, and that alkamides and Echinacea extracts might be useful in 
potentiating some chemotherapeutics which are substrates for P-gp. 
Key words: Echinacea; Alkamides; Ketones; Permeability; P-glycoprotein; Caco-2; 
 
63 
   
Introduction 
Plant materials from the genus Echinacea have been widely used for centuries in North 
America and later in Europe for the treatment and prevention of upper respiratory tract 
infections, such as the common cold and influenza (Barnes et al., 2005; Kligler, 2003).  
Echinacea supplements were the most commonly used nonvitamin, nonmineral, natural 
products both for adults and children according to 2007 NHIS survey (National Health 
Interview Survey, 2007).  Species of Echinacea, such as E. angustifolia, E. pallida, E. 
sanguinea and E. purpurea, have immune modulatory, antiviral, and antibacterial activities 
(Borchers et al., 2000; Pleschka et al. 2009; Sharma et al., 2010).   
 
E. pallida is one of the most medicinally used Echinacea species in the US and Europe and 
is being introduced into other regions due to the increasing popularity in alternative herbal 
remedies.  E. sanguinea has been neglected in the scientific literature, however, Birt et al., 
(2008) reported that E. sanguinea ethanolic extract had greater anti-inflammatory activity 
in terms of the significant reduction of prostaglandin E 2 (PGE2) production in 
lipopolysaccharide (LPS) stimulated RAW264.7 macrophages, than E. angustifolia, E. 
pallida, and E. simulata.  Studies with pure compounds and plant extract fractions indicate 
that Echinacea species are rich in bioactive chemicals of which lipophilic alkamides and 
ketones, intermediately hydrophilic phenolic compounds (mainly caffeic acid derivatives) 
and polysaccharides are the most recognized for their immunomodulatory properties 
(Barnes et al., 2005).  Bauer alkamides 8 
((2E,4E,8Z,10Z)-N-isobutyldodeca-2,4,8,10-tetraenamide), 10 
((2E,4E,8Z)-N-isobutyldodeca-2,4,8-trienamide) and 11 
((2E,4E)-N-isobutyldodeca-2,4-dienamide) at 50 µM and ketone 24 
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(pentadeca-8Z-ene-11,13-diyn-2-one) at 5 µM (Figure 1) possess anti-inflammatory 
properties because they have been shown to significantly reduce nitric oxide and 
prostaglandin E (2) production in lipopolysaccharide stimulated RAW264.7 macrophages 
(LaLone et al., 2007).  These alkamides also inhibit Cu (II) - catalyzed oxidation of human 
low-density lipoprotein in vitro (Dalby-Brown et al., 2005).   
 
Despite many in vitro studies ascribing biological activities to both the alkamides and 
ketones, these activities in vivo are possible only if they are absorbed.  Woelkart et al. 
(2005) found about 5% of the ingested dose of Bauer alkamide 8 and 1% of Bauer alkamide 
10 (Figure 1) in human blood 3 h after oral administration of a 60% ethanolic extract of E. 
angustifolia containing 0.4-2 mg of Bauer alkamide 8 and 10 (Figure 1).  Jager et al. (2005) 
and Matthias et al (2005) showed the Papp (Apparent permeability coefficients), ranging 
from 3 × 10-6 to 3 × 10-4 cm/s, for various alkamides through Caco-2 monolayers, which 
was correlated to structural variations.  But very few studies have focused on the 
metabolism of the bioavailable alkylamides (Toselli et al., 2010) and it is essential to 
understand the fate of alkylamides after ingestion because the metabolites may have 
lessened bioactivities compared with the parent compound (Cech et al., 2006).  Caco-2 
cells are immortalized human epithelial colorectal adenocarcinoma cells and offer a 
standard rapid, reliable, and low-cost model for in vitro prediction of intestinal drug 
permeability and absorption (Hubatsch et al., 2007).  Moreover, the plant material matrix 
may alter absorption or metabolism and, consequently, the bioavailability of 
phytochemicals (Manach et al., 2004).  Therefore, it is crucial to investigate the effect that 
the plant matrix may have on the uptake of key components found in Echinacea species.  
Neither in vitro studies have been done in association with the uptake of Bauer alkamides 
and ketones in different species of Echinacea, nor have the mechanism and metabolism 
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been investigated for their influence on pure compound uptake.  In addition, our 
preliminary experiments showed that alkamide 8, 10, 11 and ketone 24 were only present in 
E. pallida and E. sanguinea ethanol extracts, but not in E. angustifolia and E.simulata 
ethanolic extracts (data not published).  Therefore, E. pallida and E. sanguinea were 
chosen in this study to investigate their absorption and metabolism. 
 
Previous study showed that n-hexane root extracts from E. pallida, E. angustifolia and E. 
purpurea (30 µg/mL) inhibited multidrug transporter P-glycoprotein (P-gp) activity in a 
human proximal tubular cell line (Romiti et al., 2008).  P-gp transporter plays a key role in 
drug absorption and distribution because it limits the permeability across the GI 
(gastrointestinal) tract (Hunter and Hirst, 1997) by active efflux of potentially toxic 
substances back into the intestinal lumen.  The transporter is also expressed in other 
tissues such as liver, kidney and blood–brain barrier where it also plays an important 
excretory role.  On the other hand, P-gp confers resistance to anticancer chemotherapy 
because it is over-expressed in cancer cells (O'Connor 2007).   The elucidation of the 
mechanisms by which botanicals mediate anticancer activities (i.e. inhibition of ABC 
transporters) may allow a new paradigm of clinically useful drug resistance circumvention.   
 
Our hypotheses were that the absorbability of Bauer alkamides and ketones was 
independent of the plant extract matrix, alkamides and ketones were glucuronidated, and 
that ethanolic extracts of E. pallida and E. sanguinea extracts containing alkamides would 
inhibit P-gp activities in Caco-2 cells.  This study was conducted to investigate not only 
the effect on epithelial barrier permeabilities and metabolism of Bauer alkamides and 
ketones as pure compounds and in E. pallida and E. sanguinea ethanol extracts across 
Caco-2 cell monolayers, but also the inhibitory effects of pure compounds and plant 
66 
   
extracts on P-gp, to facilitate future studies of the efficacy of these herbs against 
inflammation and herb-drug interactions. 
 
2. Materials and methods 
2.1. Plant extraction 
Plant samples were provided by the North Central Regional Plant Introduction Station 
(NCRPIS, Ames, IA) of the Agricultural Research Service of the U.S. Department of 
Agriculture.  Roots of E. pallida (PI 631293) and E. sanguinea (PI 633672) were obtained 
from the NCRPIS, harvested, dried and ground (Voucher records: Inventory sample: PI 
631293 SD 97ncao01; PI 633672 SD 97ncao01).  Dried Echinacea root per population (6 
g) were extracted with 500 mL of 95% ethanol by Soxhlet percolation for 6 h, filtered, dried 
by rotary evaporation and lyophilized.  Then the extracts were redissolved in 0.5 mL of 
ethanol and stored at -20 °C under nitrogen.  Information about the specific provenance of 
both accessions obtained from the NCRPIS is available on the Germplasm Resources 
Information Network database at http://www.ars-grin.gov/npgs/acc/acc_queries.html. 
 
2.2. Bauer alkamide and ketone synthesis 
Chemical synthesis of Bauer alkamides and ketones (Bauer et al., 1988) were conducted 
according to the procedures described by Wu et al. (2004) and Bae (2006).  Alkamide and 
ketone concentrations were calculated after correcting for percent purity, yielding 
concentrations equivalent to 100 % pure synthetic constituent.  Calculated percent purity 
before correction for Bauer alkylamide 8 was 70%, Bauer alkylamide 10 was 82 %, Bauer 
alkylamide 11 was 92 %, and Bauer ketone 24 was 99%.  All synthetic Bauer alkamides 
and ketone were dissolved in DMSO and stored at -80 °C under argon gas.   
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2.3. HPLC analysis 
Methanol and acetonitrile (HPLC grade) were obtained from Fisher Scientific (Pittsburgh, 
PA).  HPLC analysis was performed on a Beckman Coulter 126 HPLC, equipped with 
photodiode array detector model 168 and a model 508 autosampler (Beckman Coulter, Inc., 
Brea, CA).  The mobile phase was CH3CN/H2O at a flow rate of 1.0 ml/min following a 
linear gradient of 40–80% CH3CN in H2O over 45 min.  A reverse phase analytical YMC 
pack-ODS C18 column (250 mm× 4.6 mm × 5 μm, Waters Corp., Milford, MA ) was used at 
room temperature.  The wavelength was 260 nm and the retention times were 25.4 min for 
Bauer alkamide 8, 29.1 min for Bauer alkamide 10, 35.6 min for Bauer alkamide 11, and 
17.6 min for Bauer ketone 24.  The limit of detection (LOD) and limit of quantitation 
(LOQ), defined as a signal/noise ratio ≥ 3 and ≥ 6, was 0.04 μM and 0.08 μM for Bauer 
alkamide 8, 10 and 11, 0.5 μM and 1.0 μM for Bauer ketone 24.  The linear regression 
equation for Bauer alkamide 8 was y = 27.234x - 0.3108 with R2 of 0.9996, y = 75.084x + 
0.3075 with R2 of 0.9995 for Bauer alkamide 10, y = 36.758x - 0.2493 with R2 of 0.9999 
for Bauer alkamide 11 and y = 73.532x + 0.0716 with R2 of 0.9994 for Bauer ketone 24, 
where y is the concentration of pure compound, and x is the ratio of peak area of the 
standard to peak area of the internal standard (2E,4E-hexadienoic acid isobutylamide, 
ChromaDex, Irvine, CA).  The intraday and interday CVs were 6.1 ± 2.1 % and 2.1 ± 0.4 % 
for Bauer alkamide 8, and 8.4 ± 2.6 % and 5.4 ± 3.0 % for Bauer alkamide 10 , 5.8 ± 1.4 % 
and 2.0 ± 0.4 % for Bauer alkamide 11, and 8.4 ± 2.5 % and 3.6 ± 0.4 % for Bauer ketone 24 
across 0.08-100 μM. 
 
2.4 Transepithelial transfer experiment 
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Caco-2 cells were obtained from American Type Culture Collection (Manassas, VA) at 
passage 18 and all experiments were performed from passages 30–35.  The cells were 
cultured according to Hubatsch et al. (2007).  Cytotoxicity of pure compounds and 
extracts was measured according to Nasser et al. (2008).  Pure Bauer alkamides and 
ketone, at 10-1000 μM, and E. pallida and E. sanguinea ethanol extracts, at 0.1- 50 mg/mL, 
were tested for cytotoxicity.  DMSO in DMEM (Dulbecco's modified Eagle's medium, 
0.3%, Gibco Invitrogen, Carlsbad, CA) was used as control.   
 
After the cells in the flask grew to 90–100% confluency, cells were trypsinized and seeded 
on collagen-coated polytetrafluroethylene membrane inserts (0.45 μm) fitted in bicameral 
chambers (Transwell-COL, 24 mm ID, Corning Inc., Corning, NY) at 1.2 × 105 cells/cm2.  
The transepithelial electrical resistance (TEER) was tested by Millicell ERS meter (Fisher 
Sci., Pittsburgh, PA) to reflect the tightness of intercellular junctions and only cells with 
TEER ≥ 250 Ω·cm2 were used for permeability study (Hubatsch et al., 2007).  At 21 d 
post-seeding (90–100% confluence) onto the transwell membrane, pure Bauer alkamides 
and ketone and extracts at non-cytotoxic concentrations, dissolved in Hank's Buffered Salt 
Solution (HBSS, pH 7.4, Gibco Invitrogen, Carlsbad, CA), were added to the donor side 
with the receiving chamber containing 1.5 mL of HBSS.  After 15, 30, 60, and 90 min, 
solutions were collected from the receiver side.  Samples were collected from both sides at 
the end and membrane on the transwell insert was placed in 1.5 mL of ice-cold 0.5 mol 
sodium hydroxide/L and sonicated with a probe-type sonic dismembrator (Biologics Inc., 
Manassas, VA); pH was adjusted to 7.0 and all samples were injected directly to HPLC for 
analysis.  The transport experiment was performed both at 37 °C and at 4 °C.  Total 
cellular protein was determined by Coomassie (Bradford) assay (Pierce Laboratories, 
Rockford, IL). 
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2.5. Transepithelial transfer of pure compounds and extracts after treating with 
β-glucuronidase/sulfatase 
Pure Bauer alkamides and ketone and plant extracts at non-cytotoxic concentrations were 
applied to Caco-2 cells.  Twenty µL of β-glucuronidase (Type H-5 from Helix pomatia, 40 
units/L, Sigma-Aldrich Co., St. Louis, MO) were added to the post-experimental apical and 
basolateral solutions and to cell homogenates and incubated overnight at 37 °C to release 
the parent compounds.  These samples were then injected directly to HPLC. 
 
Apparent permeability coefficients (Papp) were determined using the equation (Hubatsch et 
al., 2007): Papp = (dQ / dt) (1 / (A × C0)); dQ/dt was the permeability rate constant (μmol/s); 
A was the surface area of the membrane (cm2); and C0 was the initial concentration of the 
compound (μM).  Recovery relative to the initial amount (%) was calculated as the 
proportion of the original amount that permeated through the monolayer, which was 
calculated as the amount transported divided by the initial amount in the donor side.  
Permeation rate (µmol/min/mg protein) was calculated as the amount transported divided 
by incubation time and protein content. 
 
2.6. P-gp assay 
P-gp activity was evaluated with fluorimetric measurement of the intracellular 
accumulation of calcein produced by ester hydrolysis of the P-gp substrate calcein-AM 
using VybrantTM Multidrug Resistance Assay Kit (Gibco Invitrogen, Carlsbad, CA).  
After the cells in the flask grew to 90–100% confluency, cells were trypsinized and seeded 
on 96 well plates at 1.2 × 105 cells/cm2.  Cells were preincubated for 15 min with pure 
compounds (Bauer alkamide 8, 10, 11 and ketone 24) or extracts at non-cytotoxic 
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concentrations, thereafter calcein-AM was added and the fluorescence measured after 1 
hour using microtiter plate reader Bio-Tek ELX 808 (Bio-Tek instruments. Inc., Winooski, 
VT) at 490 nm.  The control group received vehicle alone (DMSO in DMEM, 0.3% v/v).  
The known P-gp inhibitor verapamil (10 µg/mL) was used as a control.  
 
2.7. Statistical analysis 
Data are given as means ± S. D.  Differences in cytotoxicity, Papp, transport kinetics, 
permeation rate, and absorbance representing calcein efflux by P-gp among treatments 
were evaluated statistically using two-sample t-test, ANOVA and Tukey’s multiple 
comparison tests by SAS 9.1 (SAS Institute Inc., Cary, NC).  Differences were considered 
significant at p < 0.05 and p < 0.01. 
 
3. Results 
3.1. Determination of alkamides and ketone concentrations in E. sanguinea and E. pallida 
ethanol extracts 
Bauer alkamide 8, 10 and 11 as well as ketone 24 were all present in Echinacea species 
studied, but with different profiles (Table 1).  E. sanguinea ethanol extract had ~three fold 
greater Bauer alkamide 8 and ~six fold greater Bauer ketone 24 than E. pallida accession 
on mole basis. The amount of Bauer alkamide 11 in E. pallida was about six fold more than 
E. sanguinea and Bauer alkamide 10 content was similar in two species.  Bauer alkamide 
8 and ketone 24 were more concentrated in both Echineacea species compared with Bauer 
alkamide 10 and 11.  
 
3.2 Cytotoxicity test 
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The concentrations of pure Bauer alkamide 8 greater than 350 μM, 950 μM for pure Bauer 
alkamide 10, 460 μM for pure Bauer alkamide 11, and 990 μM for pure Bauer ketone 24 
were significantly cytotoxic compared with the control (0.3% DMSO in DMEM, p < 0.05).  
Ethanol extracts of E.sanguinea and E. pallida up to 5 mg/mL (containing 425 µM of 
alkamide 8, 10 µM of alkamide 10, and 3.5 µM of alkamide 11) and 20 mg/mL (containing 
860 µM of alkamide 8,100 µM of alkamide 10, and 180 µM of alkamide 11) were 
significantly cytotoxic to the cells, respectively.  Therefore, 10, 25, 50, 100 μM of pure 
Bauer alkamides, ketone 24, and E. sanguinea and E. pallida ethanol extracts containing 
the same concentrations of each compound were used for permeability studies. 
 
3.3. Transepithelial transfer of pure compounds and extracts before and after treating with 
β-glucuronidase/sulfatase 
Figure 2A shows the relationship between the initial permeation rate of Bauer alkamides 
and concentration.  The rate of membrane permeation was calculated for Bauer alkamides 
as pure compounds.  The uptake of Bauer alkamide 8, 10 and 11 increased linearly and 
exhibited non-saturable transport across the tested concentrations (10- 100 µM, Figure 2A).  
Bidirectional permeation of three Bauer alkamides across Caco-2 cell monolayers was 
examined.  Transport rate of Bauer alkamide 8, 10 and 11 in the basolateral to apical 
(BL–AP) direction was nearly the same as that in the apical to basolateral (AP–BL) 
direction at each tested time point (Figure 2B, p > 0.05).  The transepithelial transport in 
the two directions was not saturated within 90 min as shown in Figure 2B.  The transport 
of Bauer alkamide 8, 10 and 11 across Caco-2 cell monolayers was investigated at both 
37 °C and 4 °C to evaluate the effect of temperature on the transport of three alkamides 
(AP-BL, Figure 2C).  No significant differences were found in the permeation rates of 
three alkamides at 37 °C compared with that at 4 °C (p < 0.05).   
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Further, there are differences in permeability that correlate with variations in alkamide 
structure and the rank of the permeation of three alkamides was Bauer alkamide 8 > 10 > 11 
(Table 2, Figure 2A, B and C).  No Bauer alkamide 11 was found in the basolateral side 
when 10 µM of the pure compound was applied to the apical side, which was due to the 
lesser permeability of Bauer alkamide 11 compared with Bauer alkamide 8 and 10.  No 
significant differences were found between alkamides as pure compounds compared to 
alkamides present in both E. sanguinea or E. pallida extracts (p > 0.05) in apparent 
permeability coefficients before deconjugation with β-glucuronidase (Papp, Table 2). 
 
Formation of glucuronide conjugates during transcellular transport of the alkamides was 
investigated.  After addition of the alkamides to the apical side of Caco-2 monolayers, 
glucuronide metabolites of three alkamides in the E. sanguinea extract were found in all 
compartments, including apical and basolateral sides as well as cell lysates, compared with 
only in apical side for pure Bauer alkamide 8, in apical side and cells for pure Bauer 
alkamide 10 as well as in basolateral side and cells for pure Bauer alkamide 11 (Figure 3A, 
B and C).  Interestingly, glucuronide conjugates were only detected basolaterally for 
Bauer alkamide 8 and 10 from E. pallida extract (Figure 2 A and B), and only in cells for 
Bauer alkamide 11 from E. pallida extract (p < 0.05, Figure 3C).   
 
The Papp for Bauer ketone 24 in E. sanguinea and E. pallida ethanol extracts were 17.1 ± 
7.8 and 12.2 ± 3.2 cm/s ×10-6 with no significant difference (p > 0.05, Table 2), while Bauer 
ketone 24 was not found either apically or basolaterally nor in cell lysates at each time point 
(15-90 min) across tested concentrations (10-100 µM).  Two unknown peaks were 
detected (retention time 13.3 and 15.4 min) in both apical and basolateral chambers and 
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cells after treating the Caco-2 cells with pure ketone 24, but not for the compound as found 
in the two plant extracts (Figure 4B, C and D), which implies that pure Bauer ketone 24 
was metabolized to more hydrophilic metabolites but this biotransformation was inhibited 
by other constituents in Echinacea extracts.  After β-glucuronidase treatment, Bauer 
ketone 24 recovery relative to the applied amount was significantly increased both 
basolaterally and in cells for the compound contained in E. sanguinea and E. pallida 
extracts (Figure 3D).   Papp was significantly increased for three alkamides and Bauer 
ketone 24 in E. sanguinea extract and for Bauer alkamide 8, 10 and ketone 24 in E. pallida 
extract compared with pure compounds after deconjugation with β-glucuronidase (p < 0.05, 
Table 2). 
 
3.4. Pgp inhibition by pure alkamides, E. sanguinea and E. pallida ethanol extracts 
In the present study, the modulatory effects on P-gp activity of ethanol extracts of  
E. sanguinea and E. pallida as well as pure alkamides and ketone were investigated.  As 
shown in Figure 5, After purity correction, pure Bauer alkamide 8 at 175 µM, Bauer 
alkamide 8 at 205 µM, Bauer alkamide 11 at 230 µM significantly inhibited P-gp activity 
(p < 0.05), but Bauer ketone 24 was not active across the tested concentrations (1-250 µM).  
The ethanolic extracts of E. sanguinea and E. pallida significantly inhibited P-gp at 1 
mg/mL (containing 85 µM of alkamide 8, 2 µM of alkamide 10, and 0.7 µM of alkamide 11) 
and 5 mg/mL (containing 215 µM of alkamide 8, 25 µM of alkamide 10, and 45 µM of 
alkamide 11), respectively (Figure 5).  
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4. Discussion 
This study investigated the uptake and metabolism of alkamides and ketone, when 
introduced as pure compounds or as components of the complex ethanolic extracts of 
Echinacea to cultures of the human intestinal epithelial cell line, Caco-2.  The objective 
was to explore the effect that the compound structure and the plant matrix may have on the 
intestinal uptake and metabolism of alkamides and ketone from a traditional medicinal 
plant.  We also used Caco-2 cells to study the interaction of alkamides and Echinacea 
ethanol extracts with P-gp, to identify compounds that could potentially inhibit P-gp. 
 
The transport of pure alkamides and the accumulation from both the apical and basolateral 
sides of the cells were studied.  Because Bauer alkamide 8 was considered to be absorbed 
via passive diffusion (Jager et al., 2002), it was expected that other alkamides would also be 
absorbed via similar pathway across Caco-2 cells.  This is supported by the finding that the 
rate of membrane permeation of three alkamides increased linearly with concentration, was 
not saturable during the tested incubation period (15-90 min) and was not different between 
AP-BL and BL-AP direction (Figure 2A and B).  Further, the transport of three alkamides 
was temperature independent (Figure 2C), which indicates passive diffusion through the 
Caco-2 cells.  Because an active mechanism is involved, the transport of the molecule is 
almost completely abolished at 4°C compared with 37°C (Said et al., 2003).  
 
The order of the uptake of three alkamides was Bauer alkamide 8 > 10 > 11, consistent with 
Papp for Bauer alkamide 8, ~2.5 fold and ~15 fold greater than that of Bauer alkamide 10 
and 11, respectively (Table 2).  This trend for increases in hydrophilicity giving rise to 
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increases in the apparent permeability was also seen for the family of alkamides (Matthias 
et al., 2005).   
 
Monohydroxylated, monoepoxidized, N-dealkylated metabolites were reported after 
incubation of parent Bauer alkamide 8 with both NADPH and human liver microsomes 
(Matthias et al., 2005b).  But no studies have investigated Phase II biotransformation of 
alkamides.  Various amides, including aliphatic amides, cyclic amides and sulphonamides, 
have been reported to undergo N-glucuronidation as a major elimination pathway (Sanna, 
2010).  In our study, after treating the post-experimental apical and basolateral solutions 
and cell lysates with β-glucuronidase, the amount of the parent compound increased by 
~1.5 to 4.2 fold for Bauer alkamide 8, 10 and 11 in apical side, basolateral side or cell 
lysates, indicating that alkamides were seemingly N-glucuronidated to some extent based 
on the amide structure (O-glucuronide might be hard to form because of the steric 
hinderance, Figure 1), revealing another important metabolic pathway for alkamides 
besides cytochromes P450.  E. sanguinea constituents increased total glucuronide 
formation for all alkamides, suggesting allosteric activation by plant constituents other than 
alkamides, given the short time frame for the observed apparent stimulation of UDP 
glucuronosyltransferases (UGTs).  Caffeic acid (0.6 mmol), quercetin, and apigenin (2-38 
nmol), which were all found in Echinacea species, induced UGTs expression both in 
animal models and in cell lines (Svehlíková et al., 2004; Debersa et al., 2001; Galijatovic et 
al., 2000). 
 
It is critical to investigate the effect of the plant matrix on the bioavailability of their 
bioactive compounds because the complex constituents may alter absorption or metabolism 
and, consequently, the bioavailability of phytochemicals by the influences on Phase I and II 
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enzymes and transporters.  The plant extracts did not affect transport of pure alkamides 
before deconjugation with β-glucuronidase (Table 2), establishing that the uptake of 
alkamides was independent of the of the plant extract matrix for the two Echinacea species 
studied.  This observation might be due to the transport mechanism of alkamides—passive 
diffusion across Caco-2 cell monolayers, without transporter mediated uptake involved for 
the parent compound.  Our study is the first to report the effect of Echinacea species on the 
metabolism of alkamides and ketone.  Interestingly, the recovery relative to the initial 
amount applied to the cells after β-glucuronidase hydrolysis was significantly increased in 
all compartments of the system, including apical and basolateral side as well as cell lysates, 
for all three alkamides studied in E. sanguinea extract.  These results suggest that other 
constituents contained in Echinacea species might regulate the expression of MRP 
(multidrug resistance-associated protein) or OATP (organic anion transporter protein) 
transporters which in turn affect the permeation of glucuronidated alkamides, because 
anionic conjugates (glutathione, glucuronide or sulfate) cannot exit cells unless an MRP or 
OATP transporter is present (Peng et al. 1999).  E. pallida ethanol extract inhibited the 
efflux of glucuronides of Bauer alkamide 8 and 10 apically (lumen) while enhancing the 
transfer of the conjugates basolaterally (systemic), which was not found for Bauer 
alkamide 11, indicating that alkamide conjugates may have different structural affinity to 
the efflux transporters (i.e. MRPs) and that greater amounts of Bauer alkamide 8 and 10 
from plant sources may enter systemic circulation, compared with Bauer alkamide 11, after 
deconjugation by microbial β-glucuronidase leading to stronger immune modulatory 
effects.   
 
The permeability and metabolism of Bauer ketone 24 were investigated as pure compound 
and the compound contained in Echinacea species.  Pure Bauer ketone 24 might be 
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metabolized by CYP 450 based on the diene structure and ketone group.  It has been 
shown that there is a strong overlap between substrates for gut metabolism by CYPs and 
gut active efflux by P-gp, suggesting that these two processes may work together to affect 
the intestinal absorption of a variety of drugs (Wacher et al., 1995).  Therefore, P-gp 
transporter, located along the apical membrane of the enterocytes, might be involved in the 
efflux of Bauer ketone 24 metabolites.  The transport of Bauer ketone 24 metabolites to 
the basolateral side might be due to passive diffusion along the concentration gradient.  
More interestingly, about 5% of the Bauer ketone 24 was recovered in the basolateral side 
for the compound contained in two Echinacea species, and the Papp for Bauer ketone 24 was 
similar to that of Bauer alkamide 10 (Table 2).  The reason for the difference in 
permeability of Bauer ketone 24 as pure compound or that in Echinacea species might be 
due to the effects of other constituents contained in the herb extract, because several 
Echinacea species (11.2 – 2447 µg/mL) have been shown to inhibit CYP 2C19, 2D6, and 
3A4 by 20-100 %, and alkamides contributed to the inhibitory effects seen with Echinacea 
preparations (Modarai et al., 2007).  Pure Bauer alkamide 8, 10 and 11 were incubated 
with ketone 24 across 10-100 µM, but ketone 24 was still totally metabolized as pure 
compound (data not shown).  This implies that the CYP isoforms inhibited by those 
alkamides were not involved in the biotransformation of ketone 24, although we can not 
rule out the possibility that the doses of those alkamides were too low to exhibit inhibitory 
effects.  Bioactivity of these metabolites should be examined to determine the influence of 
intestinal metabolism on bioavailability of the alkamides and ketones.   How the plant 
constituents alter glucuronidation also needs to be understood as this has implications for 
herb/drug interactions.  
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P-gp actively effluxes a wide range of structurally diverse anticancer agents and 
P-gp-mediated multidrug resistance (MDR) has been associated with inhibition of 
caspase-dependent tumor cell apoptosis (Smyth et al., 1998).  One strategy for reversal of 
MDR in cells expressing ABC transporters is combined use of anticancer drugs with 
modulators.  Inhibitors of ABC transporters, like P-gp and MRP1, can be used to enhance 
effects of anticancer drugs in patients with MDR.  In our study, E. sanguinea (1 mg/mL, 
containing 85 µM of alkamide 8, 2 µM of alkamide 10, and 0.7 µM of alkamide 11) and E. 
pallida (5 mg/mL, containing 215 µM of alkamide 8, 25 µM of alkamide 10, and 45 µM of 
alkamide 11) significantly inhibited P-gp-mediated efflux of calcein AM, a substrate for 
P-gp, indicating that alkamides were potentiated in the inhibition on P-gp by other plant 
extract constituents.  For example, quercetin at 100 µM inhibited 30 % of P-gp mediated 
efflux of [3H]-taxol in Caco-2 cells (Hayeshi et al., 2006).  There might be some 
interactions between glucuronidation and P-gp modulation, because coregulation of UGTs 
and ABC transporters by AhR (Ah-receptor) ligands has been studied in Caco-2 cells 
(Walle et al., 1999; Bock et al., 2000; Bock-Hennig et al., 2002) showing that AhR, PXR 
(pregnane X receptor), and CAR (constitutive androstane receptor) found in 
promoter/enhancer region of the UGT gene might also be involved in the regulation of 
ABC transporters (Bock and Bock-Hennig, 2010).  Further, the concentrations of 
Echinacea plant extracts that inhibited of P-gp in our study were greater than in a published 
paper showing that extracts of roots of Echinacea species inhibited P-gp in human 
proximal tubular kidney cells, and E. pallida extract was the most active at 3 μg/mL 
compared with E. angustifolia and E. purpurea both at 30 μg/mL (Romiti et al. 2008).  
This might be due to the difference in the cell lines used or the preparation of the extracts 
(extraction ratio (raw material weight: final solution volume) was 12:1 in our study and 
125:1 in Romiti’s study).  The concentrations of Echinacea extracts showing inhibitory 
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activities of P-gp were greater than the concentrations of E. sanguinea and E. pallida 
containing 10-100 µM of Bauer ketone 24 (0.08-0.8 mg/mL and 0.3-3.4 mg/mL, 
respectively), thus P-gp might not be inhibited and was able to efflux pure Bauer ketone 24 
metabolites in our permeability study (Table 2 and Figure 4).  Romiti et al. (2008) found 
that the lipophilic ketones isolated from E. pallida roots, namely 
8-hydroxypentadeca-(9E)-ene- 11,13-diyn-2-one, 8-hydroxypentadeca- (9E,13Z)- 
dien-11-yn-2-one, pentadeca-(9E)-ene-11,13-diyne-2,8-dione, pentadeca-(9E,13Z)- 
dien-11-yne-2,8-dione and pentadeca-(8Z,13Z)-dien-11-yn-2-one, in the range of 200-800 
µM, inhibited P-gp.  Our study is the first report of pure Bauer alkamide 8, 10 and 
11(greater than the amount contained in E. sanguinea at 1 mg/mL or E. pallida at 5 mg/mL) 
inhibiting P-gp mediated efflux in Caco-2 cells, which may have implications for 
anti-colitic or colon cancer drug interactions with P-gp.  Because we have shown that 
alkamides are apparently glucuronidated, even though they are probably most absorbed in 
the small intestine, the glucuronides will be effluxed to the lumen to some extent, although 
not for the alkamides in E. pallida, and they would also be susceptible to biliary excretion 
into the intestine.  Although N-glucuronides are more slowly hydrolyzed by 
β-glucuronidase, produced by gut bacteria, than O-glucuronides or S-glucuronides 
(Casarett and Doull, 2008), the parent alkamides would still be available to act in the large 
intestine.  In the current study we analyze each chemically synthesized preparation prior to 
its use as an inhibitor of P-gp function, allowing for impurities in the alkamide preparations, 
and normalizing to a concentration at 100% purity; this normalization allowed for greater 
sensitivity in our screening of P-gp inhibition using the caco-2 intestinal cell line.  In 
addition, alkamides were highly permeable, which permits their interaction with P-gp, 
since its binding sites are either inside the bilayer or at the inner leaflet of the cell 
membrane (c and Clarke, 2005).  Although glucuronidation may prevent tissue uptake of 
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the alkamides, glucuronidase produced by liver and neutrophils (O'Leary et al., 2001; 
Bartholomé et al., 2010) may convert the glucuronide conjugates to parent compounds and 
alkamides may enter the hepatic portal vein at relative high concentrations, possibly 
permitting alkamide inhibitory activity of P-gp in tissues throughout the body. 
 
In conclusion, Bauer alkamide 8, 10 and 11 were transferred across Caco-2 cells, 
independent of extract matrix, thus results on efficacy of the pure compounds may 
reasonably be extrapolated to results using plant materials containing these compounds.  
Alkamides were seemingly N-glucuronidated to some extent and Bauer ketone 24 was 
transferred and metabolized to glucuronide conjugates as the compound from plant extracts 
but not as pure compound, strongly suggesting that alkamides and Bauer ketone 24 in 
Echinacea species had a more extensive metabolism in the Caco-2 cells than pure 
compounds, and that plant matrix may have a facilitating effect on the metabolism of 
alkamides and ketones from Echinacea.  Because the Caco-2 cell model is considered to 
be a good predictive model for human gastro-intestinal absorption, the results obtained 
should also closely reflect the in vivo intestinal uptake and metabolism of alkamides and 
ketones expected when Echinacea plant extracts and supplements are given to humans.  
Bauer alkamide 8, 10 and 11 as well as E. sanguinea and E. pallida extracts inhibited P-gp 
mediated efflux in Caco-2 cells.  Considering the increasing knowledge about the role of 
P-gp in cancer resistance and the worldwide increasing use of Echinacea preparations, 
further studies in humans are required to specifically investigate the uptake and metabolism 
of alkamides and ketones derived from natural plant products in humans.  The reason for 
the enhanced metabolism by other accompanying constituents in plant extracts should also 
be established.  Because Echinacea supplements are usually ingested on a chronic basis, 
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their long term effects on the metabolizing enzymes and expression of efflux transporters 
needs to be investigated and may be of importance regarding herb–drug interactions. 
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Figures 
  
Figure 1.  The chemical structures of Bauer alkamide 8, 10, 11 and ketone 24.  
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Figure 2.  Transport of pure Bauer alkamide 8, 10 and 11 across Caco-2 cells.  A. 
Concentration dependency of the transport of three alkamides.  B. Non- saturable 
transport of three alkamides at 25 µM during 90 min incubation period with no difference 
between apical to basolateral (AP-BL) and basolateral to apical (BL-AP) direction at each 
time point.  C. The effect of temperature on the transport of the three alkamides (37°C vs 
4°C).  Means bearing different letters were significantly different among three alkamides 
by ANOVA and Tukey’s multiple comparison (p < 0.05).  Data are the mean ± S. D. 
(n=6). 
 
 
 
85 
   
 
 
 
86 
   
 
Figure 3.  Glucuronidation of Bauer alkamide 8, 10, 11 and ketone 24 for pure compounds 
or from plant extracts by Caco-2 cells.  Before, prior to deconjugation with 
β-glucuronidase.  After , subsequent to deconjugation with β-glucuronidase.  The 
concentration of three Bauer alkamides and ketone 24 was 25 µM both for pure compounds 
or as found in the two Echinacea extracts.  A. Bauer alkamide 8.  B. Bauer alkamide 10.  
C. Bauer alkamide 11.  D. Bauer ketone 24.  * Significantly different compared with the 
recovery relative to the initial amount before the enzyme treatment by two-sample t-test (p 
< 0.05).  Data are the mean ± S. D (n=6).   
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Figure 4.  HPLC chromatograms of Bauer ketone 24 across Caco-2 cell monolayers as 
pure compound or from Echinacea species.  A. Bauer ketone 24 standard at 100 µM 
(retention time 17.6 min).  B. Bauer ketone 24 (100 µM) was not detected in the 
basolateral supernatant fluid, but two more hydrophilic metabolites were detected 
(retention time 13.3 and 15.4 min).  C. Bauer ketone 24 was shown in the basolateral side 
after apically applied E. sanguinea containing 100 µM of ketone 24 (retention time 17.6 
min).  D. Bauer ketone 24 was shown in the basolateral side after apically applied E. 
pallida containing 100 µM of ketone 24 (retention time 17.6 min). 
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Figure 5.  The effects of Bauer alkamide 8, 10, 11, ketone 24 on P-glycoprotein transporter 
activity.   Control was 0.3% DMSO in PBS.  Verapamil was used as positive control at 
10 µg/mL.  * Significantly different compared with control by two-sample t-test (p < 0.05).  
** Significantly different compared with control by two-sample t-test (p < 0.01).  Data are 
the mean ± S. D (n=6).  The ethanolic extract of E. sanguinea at 1 mg/mL contained 85 
µM of alkamide 8, 2 µM of alkamide 10, and 0.7 µM of alkamide 11, and 5 mg/mL of E. 
pallida extract containecd 215 µM of alkamide 8, 25 µM of alkamide 10, and 45 µM of 
alkamide 11. 
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Table 1. The concentrations of alkamides and ketone in Echinacea ethanol extracts 
determined by HPLCa. 
 a E. sanguinea and E. pallida ethanolic extracts were diluted by methanol for HPLC 
analysis (n=9).  All values are means± SD. b PI, assession number. 
 
Bauer  
alkamide 8 
g/L(mM) 
Bauer 
alkamide10  
g/L(mM) 
Bauer 
alkamide11 
g/L(mM) 
Bauer  
ketone 24     
g/L(mM) 
E. sanguinea 
(PI 633672, 154.3 g/Lb) 
3.2 ± 0.2 
(13.1 ± 0.7) 
0.1 ± 0.01 
(0.3 ± 0.02) 
0.03 ± 0.01 
(0.1 ± 0.04) 
3.8 ± 0.5 
(17.3 ± 2.5) 
E. pallida 
(PI 631293, 99.0 g/L ) 
1.1 ± 0.1 
(4.3 ± 0.3) 
0.1 ± 0.01 
(0.5 ± 0.02) 
0.2 ± 0.03  
(0.9 ± 0.1) 
0.6 ± 0.04  
(2.9 ± 0.2) 
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Table 2. Apparent permeability coefficients (Papp) for pure alkamides and extracts across 
the Caco-2 monolayera. 
 
Papp (cm/s ×10-6) 
Bauer 
alkamide 8 
Bauer  
alkamide 10 
Bauer  
alkamide 11 
Bauer 
ketone 24 
Before d After Before After Before After Before After 
Pure 
compound b 
43.8 ± 
11.2 a 
39.8 ± 
13.4 b 
17.7 ± 
8.8 a 
18.3 ± 
5.9 b 
2.8 ± 
1.5 a 
9.7 ± 
2.3*a ND
 e ND 
E. sanguinea c 
54.6 ± 
13.2 a 
76.8 ± 
11.7 *a 
12.9 ± 
5.6 a 
28.4 ± 
4.1*a 
3.7 ± 
1.9 a 
8.2 ± 
2.4*a 
12.2 ± 
3.2 a 
22.9 
±6.3*a 
E. pallida  41.3 ± 7.4 a 
65.2 ± 
6.8 *a 
14.7 ± 
4.2 a 
22.3 ± 
7.9*a 
5.4 ± 
2.5 a 
4.3 ± 
1.9 b 
17.1 ± 
7.8 a 
28.4 ± 
6.3*a 
a All values are means ± SD (n=9). TEER was 460-573 Ω·cm2.  Means bearing different 
letters were significantly different in each column (p < 0.05). 
b Bauer alkamide 8, 10, 11 and ketone 24 were 10-100 μM for pure compounds.   
c Two herb extracts were diluted to contain same concentrations of Bauer alkamide 8, 10, 
11 or ketone 24 as the pure compounds.  
d Before = before deconjugation; After = after deconjugation.  
e Bauer ketone 24 was not detected in the receiver side for pure compound.  
* Significantly different compared with the Papp before deconjugation with β-glucuronidase 
by ANOVA and Tukey’s multiple comparison.  
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Abstract 
Ethnopharmacological relevance Rosmarinic acid (RA), a caffeic acid derivative found 
in high concentrations in Prunella vulgaris (self-heal), and ursolic acid (UA), a pentacyclic 
triterpene acid concentrated in Salvia officinalis (sage), have been traditionally used to treat 
inflammation in the oral cavity, and may also be of benefit to gastrointestinal health in 
general.   
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Aim of the study To investigate the permeability and metabolism of RA and UA as pure 
compounds and in P. vulgaris and S. officinalis ethanol extracts across human intestinal 
epithelial Caco-2 cell monolayers.  
Materials and methods The permeability and Phase II biotransformation of RA and UA 
as pure compounds and in herbal extracts that contained same concentration as the pure 
compounds were compared using Caco-2 cells with HPLC detection.  
Results The apparent permeability coefficient (Papp) for RA and RA in P. vulgaris extracts 
was 0.2 ± 0.05 × 10-6 cm/s, significantly increased to 0.9 ± 0.2 × 10-6 cm/s after 
β-glucuronidase/sulfatase treatment.  Papp for UA and UA in S. officinalis extract was 2.7 ± 
0.3 × 10-6 cm/s and 2.3 ± 0.5 × 10-6 cm/s before and after β-glucuronidase/sulfatase 
treatment, respectively.  Neither compound was affected in permeability by the herbal 
extract matrix.   
Conclusion RA and UA in herbal extracts had similar uptake as that found using the pure 
compounds, which may simplify the prediction of compound efficacy.  The apparent lack 
of intestinal glucuronidation/sulfation of UA is likely to further enhance the bioavailability 
of that compound compared with RA. 
Key words: Prunella vulgaris; Salvia officinalis; Rosmarinic acid; Ursolic acid; 
Permeability; Caco-2 
 
100 
   
Introduction 
Rosmarinic acid (RA, Figure 1) is a caffeic acid (CA) derivative found in various 
botanicals, especially in Prunella vulgaris, a perennial herb known as self-heal used to treat 
sore throat, fever, and wounds (Psotová et al., 2003).  RA and P. vulgaris limit liver 
damage derived from a model of bacterial inflammation (Osakabe et al., 2002) and inhibit 
nervous system inflammation in another model (Swarup et al., 2007).  Ursolic acid (UA, 
Figure. 1), a pentacyclic triterpene acid, is also found in P. vulgaris but especially 
concentrated in sage leaves (Salvia officinalis), and inhibits inflammation-related changes 
in human gingival cells (Zdarilová et al., 2009) and in other models (Liu, 1995).  This 
compound also has antimutagenic activities (Filipic et al., 1997).  Both herbs have been 
used traditionally to treat inflammation in the mouth, and are of interest in inhibiting 
gastrointestinal inflammation which is relevant to colitis and colon cancer.  
 
A major limiting step in the utilization of RA and UA is their intestinal absorption and 
metabolism.  Both compounds contain hydroxyls and are likely to be glucuronidated or 
sulfated in intestinal cells, forms that are generally considered to be less bioactive than 
parent compounds.  This metabolism has been demonstrated for RA but not for UA, and 
the plant matrix components might alter this metabolism but this has not been studied yet.  
The absorption or metabolism of RA has been examined in vivo to a limited extent (Baba et 
al., 2004; Konishi et al., 2005; Baba et al., 2005).  When Perilla extract containing 200 mg 
of RA was orally administered to six men, RA in both plasma and urine was present 
predominantly as glucuronide and/or sulfate conjugated forms, at 0.6 ± 0.2% and 1.5 ± 0.4% 
of the total intake, respectively, within 48 h after ingestion (Baba et al., 2005).  Gut 
microbes may metabolize RA to give phenolics such as caffeic acid, o-coumaric acid and 
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m-hydroxyphenylpropionic acid, which are then absorbed by monocarboxylic acid 
transporter (MCT)-mediated active processes (Konishi and Kobayashi, 2005).  After the 
oral administration of Sambucus chinensis ethanol extract (40g/kg to rats, containing 80 mg 
UA/kg) about 0.6% of ingested UA was recovered in plasma based on estimated blood 
volume and plasma area under curve of this compound, suggesting poor absorption or 
extensive metabolism and distribution to other body tissues (Liao et al., 2005).  Both RA 
and UA as constituents of P. vulgaris may contribute to its bioactivities, and the effects of 
plant matrix on uptake and metabolism of its key bioactive compounds are of interest. 
 
Caco-2 cells are immortalized human epithelial colorectal adenocarcinoma cells and offer a 
standard rapid, reliable, and low-cost model for in vitro prediction of intestinal drug 
permeability and absorption (Hubatsch et al., 2007).  Caffeic acid derivatives, such as RA 
and chlorogenic acid, have been studied using Caco-2 model and are proposed to transfer 
across the intestinal barrier by paracellular diffusion (Konishi and Kobayashi, 2005; 
Konishi and Kobayashi, 2004).  The plant material matrix may alter absorption or 
metabolism and, consequently, the bioavailability of phytochemicals (Manach et al., 2004).  
P. vulgaris and S. officinalis contain sugars, steroids, alkaloids, essential oils, flavonoids, 
polyphenols, triterpenoids, and saponins (Rasool et al., 2010; Cheung and Zhang, 2008; Lu 
and Foo, 2000; Loizzo et al., 2008).  Therefore, it is crucial to investigate the effect that the 
plant matrix may have on the uptake of RA and UA found in P. vulgaris and S. officinalis.  
In vitro studies have not been done in association with the permeation of RA in P. vulgaris 
extracts using Caco-2 cells nor have different sources of P. vulgaris plant material been 
compared for their influence on RA uptake.  Uptake of UA in the Caco-2 cell model also 
has not been investigated, either as a pure compound or from plant extracts.  Our 
hypotheses were that the absorbability and metabolism of RA and UA was independent of 
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the plant extract matrix and this study was conducted to investigate the permeabilities of 
RA and UA as pure compounds and in P. vulgaris and S. officinalis ethanol extracts across 
Caco-2 cell monolayers, to facilitate future studies of the efficacy of these herbs against 
gastrointestinal inflammation.  
 
Materials and methods 
Plant extraction  
All P. vulgaris plant samples were provided by the U.S Department of Agriculture North 
Central Regional Plant Introduction Station in Ames, IA.  S. officinalis extract was 
provided by Sabinsa Corporation (Payson, UT).  Seeds from accessions P. vulgaris Ames 
27664, 27665 (both originally collected in North Carolina), and 27748 (collected in 
Missouri) were germinated in Petri plates at 25 °C (Voucher records: Herbarium specimen. 
Taken by: McCoy, J., USDA, ARS. On: 08/24/2006. Located at: ISC. Inventory sample: 
Ames 27664, 27665 and 27748. SD 04ncao01).  The resulting seedlings, segregated by 
accession, were transferred to flats in a greenhouse (held at 20–25 °C).  Upper flowering 
portions of 14-month-old plants were harvested at the time of peak flowering, dried, and 
ground.  Four g aliquots of the ground samples were extracted with 500 mL of 95% 
ethanol by Soxhlet percolation for 6 h, filtered, dried by rotary evaporation and lyophilized.  
Then the extracts were redissolved in 0.5 mL of ethanol and stored at -20 °C under nitrogen.  
Information about the P. vulgaris accessions used for these experiments is available via the 
Germplasm Resources Information Network database at 
http://www.ars-grin.gov/npgs/acc/acc_queries.html. 
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HPLC analysis 
RA (90%) and UA (92%), both from Sigma-Aldrich Co. (St. Louis, MO) and 2, 4, 4'- 
trihydroxybenzoin (THB, internal standard), synthesized in Dr. Hendrich’s laboratory 
(Song et al., 1998) were dissolved in DMSO to use them as standards.  Methanol, 
acetonitrile (HPLC grade) and phosphoric acid (AR grade) were obtained from Fisher 
Scientific (Pittsburgh, PA).  
 
HPLC analysis was performed on a Beckman Coulter 126 HPLC, equipped with 
photodiode array detector model 168 and a model 508 autosampler (Beckman Coulter, Inc., 
Brea, CA).  The mobile phase was 1.25% phosphoric acid: acetonitrile (15% acetonitrile 
at 0 min, then increased to 84% at 15 min and held for 40 min; decreased to 15% at 65 min) 
at a flow rate of 0.5 ml/min.  A reverse phase analytical YMC pack-ODS C18 column (250 
mm× 4.6 mm × 5 μm, Waters Corp., Milford, MA ) was used at room temperature.  The 
wavelength was 210 nm and the retention times were 21.5 min for RA and 26.5 min for UA.  
The limit of detection (LOD) and limit of quantitation (LOQ), defined as a signal/noise 
ratio ≥ 3 and ≥ 6, was 0.05 μM and 0.1 μM both for RA and UA.  The linear regression 
equation for RA was y = 95.256x - 0.0188 with R2 of 0.9995 and y = 236.07x + 0.0014 with 
R2 of 0.9996 for UA, where y is the concentration of RA or UA, and x is the ratio of peak 
area of the standard to peak area of the internal standard (THB).  The intraday and interday 
CVs were 7.3 ± 2.5 % and 3.4 ± 1.6 % for RA, and 9.1 ± 3.8 % and 5.7 ± 2.1 % for UA 
across 0.1-100 μM. 
 
Transepithelial transfer experiment 
Caco-2 cells were obtained from American Type Culture Collection (Manassas, VA) at 
passage 18 and all experiments were performed from passages 25–30.  The cells were 
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cultured according to Hubatsch et al. (2007).  Cytotoxicity of RA, UA, and extracts was 
measured according to Nasser et al. (2008).  RA, UA, P. vulgaris ethanol extracts 
containing the same concentrations of RA, and S. officinalis extract containing the same 
concentrations of UA, at 1, 10, 20, 50, and 100 μM in DMEM, were tested for cytotoxicity.  
DMSO in DMEM (Dulbecco's modified Eagle's medium, 0.3%, Gibco Invitrogen, 
Carlsbad, CA) was used as control.   
 
After the cells in the flask grew to 90–100% confluency, cells were trypsinized and seeded 
on collagen-coated polytetrafluroethylene membrane inserts (0.45 μm) fitted in bicameral 
chambers (Transwell-COL, 24 mm ID, Corning Inc., Corning, NY) at 1.2 × 105 cells/cm2.  
The transepithelial electrical resistance (TEER) was tested by Millicell ERS meter (Fisher 
Sci., Pittsburgh, PA) to reflect the tightness of intercellular junctions and only cells with 
TEER ≥ 250 Ω·cm2 were used for permeability study.  At 20-21 d post seeding (90–100% 
confluence) on the transwell, RA, UA and extracts at non-cytotoxic concentrations or 100 
μM of the paracellular marker, lucifer yellow (LY, Sigma-Aldrich Co., St. Louis, MO), 
dissolved in Hank's Buffered Salt Solution (HBSS, pH 7.4, Gibco Invitrogen, Carlsbad, 
CA), were added to the apical chamber, then basolateral solutions were collected after 0.5, 
1, 2, and 4 h.  After 4 h, apical solutions were collected and membrane on the transwell 
insert was placed in 1.5 mL of ice-cold 0.5 mol sodium hydroxide/L and sonicated with a 
probe-type sonic dismembrator (Biologics Inc., Manassas, VA); pH was adjusted to 7.0 
and all samples were injected directly to HPLC for analysis.  For LY quantification, the 
apical and basolateral solutions were transferred to a 96 well plate and read 
spectrophotometrically at 450 nm.  Total cellular protein was determined by Coomassie 
(Bradford) assay (Pierce Laboratories, Rockford, IL). 
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Transepithelial transfer of single compounds and extracts after treating with 
β-glucuronidase/sulfatase 
Ten μM RA as a single compound and P. vulgaris ethanol extracts diluted to contain 10 μM 
RA or 20 μM UA and S. officinalis extract diluted to contain 20 μM UA were applied to 
Caco-2 cells.  Twenty µL of β-glucuronidase/sulfatase (Type H-2 from Helix pomatia, 85 
units/L of glucuronidase and 7.5 units/L of sulfatase, Sigma-Aldrich Co., St. Louis, MO) 
were added to the post-experimental apical and basolateral solutions and to cell 
homogenates and incubated overnight at 37 °C to release the parent compounds.  These 
samples were then injected directly to HPLC. 
 
Apparent permeability coefficients (Papp) were determined using the equation (Hubatsch et 
al., 2007): Papp = (dQ / dt) (1 / (A × C0)); dQ/dt was the permeability rate constant (μmol/s); 
A was the surface area of the membrane (cm2); and C0 was the initial concentration of the 
compound (μM).  Basolateral recoveries (%) were calculated as the proportion of the 
original amount that permeated through the monolayer, which was calculated as the 
amount transported divided by the initial amount in the apical chamber.  Transport rate 
(µM/h/cm2) was calculated as the amount transported divided by incubation time and the 
area of the membrane. 
 
Statistical analysis 
Data are given as means ± S. D.  Differences in cytotoxicity, Papp, transport kinetics, 
basolateral recoveries and transport rate of the pure compounds and extracts were 
evaluated statistically using ANOVA and Tukey’s multiple comparison tests by SAS 9.1 
(SAS Institute Inc., Cary, NC).  Differences were considered significant at p < 0.05. 
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Results 
Determination of RA and UA concentrations in P. vulgaris and S. officinalis ethanol 
extracts 
The amounts of RA in ethanol extracts varied ~sixfold across the three P. vulgaris 
accessions; UA content in P. vulgaris extract was ~four- to twenty-fold less on a molar 
basis than was UA in S. officinalis extract (Table 1).  The ethanolic extract of P. vulgaris 
27748 had threefold greater RA and tenfold more UA than the two other accessions studied.  
No RA was found in the S. officinalis extract.  
 
Cytotoxicity test 
For RA as a pure compound, concentrations greater than 50 μM were significantly 
cytotoxic compared with the control (0.3% DMSO in DMEM, p < 0.05).  Ethanol extracts 
of P. vulgaris accessions containing ≥ 20 μM RA showed significant cytotoxicity.   
Concentrations ≥ 20 μM of UA as a pure compound and S. officinalis extract containing 
same amount of UA were toxic to the Caco-2 cells (data not shown).  Therefore, 1, 2, 5, 10 
μM of RA as a single compound or in P. vulgaris ethanol extracts, and 2, 5, 10, 20 μM of 
UA and S. officinalis extract containing these amounts of UA were used for permeability 
studies. 
 
Transepithelial transfer of single compounds and extracts before and after treating with 
β-glucuronidase/sulfatase 
The basolateral recovery of paracellular marker, LY, was 0.5 ± 0.1%.  In the basal 
chamber after 4 h, 1.3 ± 0.3, 1.2 ± 0.2, 1.4 ± 0.6 and 0.9 ± 0.4 % of parent RA was 
transferred for pure compound, or for RA in P. vulgaris 27664, 27665 and 27748 extracts, 
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respectively (no significant differences, p > 0.05).  The apical recoveries of RA were 86.7 
± 2.9, 85.8 ± 3.6, 81.2 ± 5.7 % and 79.1 ± 11.2 % for the pure compound, or for RA in P. 
vulgaris 27664, 27665 and 27748 extracts, respectively, with no significant differences (p > 
0.05, data not shown).  
 
The permeation rate was calculated for UA as a pure compound and UA in S. officinalis 
extract at the same doses.  The uptake of UA increased linearly and significantly from 0.03 
± 0.01 to 0.2 ± 0.04 µM/h/cm2 (p < 0.01) and was not saturable across the tested 
concentrations (5- 20 µM, Figure 2).  It was also not saturable across tested time-points 
(0.5-4 h) both for pure compounds and UA contained in S. officinalis extract (Figure 3A).  
Due to LOD of UA and the lesser amount of it in P. vulgaris extracts compared with RA, 
UA was not detected for apically-applied P. vulgaris extracts containing 1-10 μM RA.  
Basolateral recoveries of RA as pure compound and RA in P. vulgaris 27664 increased 
over time (RA in P. vulgaris 27665 and 27748 are not shown), although RA was not 
detected basolaterally at 0.5 and 1h before deconjugation (Figure 3A).  The basolateral 
transfer of UA was significantly greater than RA at each time point both for pure 
compounds or compounds contained in plant extracts (p < 0.01, Figure 3A).  No 
significant differences were found between RA as a pure compound and RA in P. vulgaris 
extracts or UA as a pure compound and UA in S. officinalis extract (p > 0.05) in apparent 
permeability coefficients (Papp, Table 2).   
 
After deconjugation using β-glucuronidase/sulfatase, RA recoveries significantly increased 
from 1.3 ± 0.3% to 6.1 ± 1.4%, 1.2 ± 0.2% to 6.5 ± 2.7 %, 1.2 ± 0.03% to 4.9 ± 0.6 %, 1.1 ± 
0.2% to 5.5 ± 1.2 % (p < 0.01) in basal chamber for the single compound, or for RA in P. 
vulgaris 27664, 27665 and 27748 extracts, respectively (Figure 3C, RA in P. vulgaris 
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27665 and 27748 are not shown).  The transfer of RA glucuronide/sulfate conjugates was 
not saturable during 4 h and increased linearly with the incubation time (p < 0.01, Figure 
3B).  Both RA as a single compound and RA in P. vulgaris extracts showed the same 
increase in Papp after deconjugation (Table 2).  To check the mass balance, the total 
recoveries (apical + basolateral) of RA increased from 80-88% before deconjugation to 
84-93% after deconjugation for pure compound and RA in extracts, with no new peaks 
detected.  The basolateral recoveries of UA were 19.0 ± 4.2% or 15.9 ± 3.2% for pure 
compound before or after incubation with β-glucuronidase/sulfatase, and 17.6 ± 2.5% or 
14.5 ± 4.3% for S. officinalis extract, not statistically different (p > 0.05, Figure 3C).  No 
significant differences were found in the apical recoveries of RA or UA (p > 0.05) and 
neither RA nor UA was found in cells before or after deconjugation.  Papp for UA or UA in 
S. officinalis extract did not change after deconjugation reaction (Table 2).   
 
Discussion 
Because in vivo absorption studies performed with laboratory animals and humans are 
expensive and time consuming and can pose ethical challenges, Caco-2 cells are a useful 
alternative to study uptake and transport of important compounds from plant materials 
(Walgren et al., 1998).  Plant matrices may influence phytochemicals by altering 
transporters of some compounds or of compound metabolites (Mukinda et al., 2010).  
Phytochemical biotransformation may also be altered by other components of the plant 
matrix.  To establish the effect that the plant matrix had on the in vitro uptake of RA and 
UA found in P. vulgaris and S. officinalis, two herbs that may be important for gut health, 
the uptake of pure solutions of the two compounds and extracts of two herbs that are major 
sources of these compounds were compared in Caco-2 cell system.   
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RA in P. vulgaris and UA in S. officinalis extracts had similar efficient absorption as that in 
pure solutions of each compound in Caco-2 cells (Figure 3A and Table 2, p > 0.05); this 
was not influenced by varied contents of RA across three accessions collected from 
different sources.  The Papp for RA in Salvia miltiorrhiza was 0.5 ± 0.3 × 10-6 cm/s in 
Caco-2 cells (Lu et al., 2008), consistent with our results.  The results are also consistent 
with in vivo studies showing poor absorption of intact RA (Baba et al., 2004), suggesting 
that the absorption of RA is independent of other constituents contained in P. vulgaris 
ethanolic extracts.  The impact of plant matrices on the bioavailability of phytochemicals 
is highly dependent on the compound of interest.  For example, the absorption of 
epicatechin was not influenced by the ingredient composition of beverage food matrices in 
vitro (Neilson et al., 2009), but Hypericum perforatum L. product matrices affected the 
transport of rutin, hyperoside and isoquercitrin across Caco-2 cells (Gao et al., 2010), 
probably due to differences in matrix phytochemical composition and transport 
characteristics, i.e. paracellular transfer, carrier mediated or active transport.  In our study, 
both RA and UA were major components of their respective plant material (~3% or greater 
by weight, and ~ 5-50 mM of ethanolic plant extract).  It could be useful to compare RA or 
UA uptake from plant matrices in which these components were less concentrated.  
Studies are also needed to investigate the influences of preservation or processing of plant 
extract on the bioavailability of RA and UA both in vitro and in vivo. 
 
If the basolateral movement of the paracellular marker, LY, is less than 0.7% and TEER 
value is greater than 250 Ω·cm2, the established monolayer is considered to be tight enough 
for permeability experiments (Ohashi et al., 2009).  In our permeability studies, we tested 
the basolateral recoveries at time points and interval times chosen for a hydrophilic 
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paracellularly transferred compound (RA) (Hubatsch et al., 2007).  RA uptake was not 
saturable during 4 h incubation period (Figure 3A), indicating that passive diffusion 
occurred for this parent compound.  We only measured the uptake of RA at 10 µM due to 
its cytotoxicity; RA was not detected at 0.5 and 1 h because of its LOD and the low 
concentration applied to the apical chamber.  Unidirectional transport (apical to 
basolateral transfer) was investigated for RA in our study and the pH of both apical and 
basolateral solutions was 7.4 (to simulate small intestine pH), because Konishi and 
Kobayashi (2005) showed that permeation of RA from the apical to the basolateral side is 
similar to that from basolateral to apical side; the uptake in the presence of a proton 
gradient (pH gradient 6.0/7.4) was nearly the same as that in the absence of a proton 
gradient (pH gradient 7.4/.4), implying that proton coupled polarized transport was not 
involved for RA.  The transepithelial flux of RA was inversely correlated with TEER in 
our experiment (data not shown), consistent with restriction of intestinal absorption of RA 
when the epithelial tight junction is tight enough, a finding similar to that shown for another 
caffeic acid derivative, chlorogenic acid (Konishi and Kobayashi, 2004).   
 
Our finding of increased basolateral RA recoveries after deconjugation (Figure 3C) is the 
first direct report of this type of intestinal metabolism of RA; glucuronide/sulfate 
conjugates were transferred to the basolateral side (toward the circulation) rather than 
apical side (the intestinal lumen), but this finding is consistent with in vivo observations of 
RA glucuronide/sulfate conjugates as major forms of this compound in rat and human 
plasma (Konishi et al., 2005; Baba et al., 2005).  These results suggest that RA is absorbed 
via both paracellular and transcellular diffusion and MRP (multidrug resistance protein) or 
OATP (organic anion transporter protein) transporters might be involved in the permeation 
of glucuronidated or sulfated RA, because anionic conjugates (glutathione, glucuronide or 
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sulfate) cannot exit cells unless an MRP transporter is present (Peng et al. 1999).  
Intestinal metabolism of RA seemingly differs from that of its possible metabolites, 
glucuronide/sulfate conjugates of caffeic acid, ferulic acid and o-coumaric acid which were 
found only apically (Kern et al., 2003).  This might be due to the specificity of MRP 
transporters to the glucuronide/sulfate conjugates of different caffeic acid derivatives and 
the locations of various MRP in apical or basolateral sides of the enterocytes (Peng et al., 
1999).           
 
The plant extracts did not affect transfer of either UA or RA, and likewise the pure 
compounds and the compounds from the plant extracts behaved similarly in their apparent 
biotransformation as well (Figure 3A, B and C and Table 2), establishing that the transfer 
and metabolism of RA and UA was independent of the of the plant extract matrix for the 
two herbs studied.  The transfer of UA seemed simpler than that observed for RA.  The 
rate of membrane permeation of UA increased linearly with concentration and was not 
saturable at the tested time-points (Figure 2, 3A and 3B), indicating uptake by passive 
diffusion.  Because the basolateral transfer of UA was greater than RA at each time point 
(Figure 3A), and the partition coefficient (Log P) of RA was 0.2, compared with Log P of 
UA of 6.4 (Konishi et al. 2005; Bérangère et al., 2004), more hydrophobic UA was more 
absorbable than RA.  This result is consistent with an interpretation of previous in vivo 
findings in rats that the low plasma concentration of UA was not due to poor absorption but 
to extensive uptake of UA by other tissues (Liao et al. 2005).  UA was absorbed and 
transferred by Caco-2 cells apparently with little glucuronidation/sulfation (Figure 3C and 
Table 2), which is likely to further enhance the bioavailability of UA compared with RA.  
This lack of UA biotransformation might be due to the differences in glucuronidation and 
sulfation of aliphatic alcohol (UA) and phenol alcohol (RA) or because of the distinct 
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structures of the two compounds: triterpenoid (UA) vs. caffeic acid derivative (RA).  But 
two studies showed that there was wide variability in affinity for 
UDP-glucuronosyltransferase (UGT) and sulfotransferase (ST) across both general classes 
of substrates (Chen et al., 1996; Ebner and Burchell, 1993).  One related triterpenoid, 
glycyrrhetinic acid (50-300 µM), was found to inhibit UGT2B7 activity in human liver 
microsomes (Nakagawa et al., 2009), which might also occur for UA.  To our knowledge, 
no other in vivo or in vitro study has been done on the metabolism of ursolic acid.  It is 
possible that UA may undergo additional glucuronide or sulfate conjugation in the liver.   
Future studies are required to elucidate the structures of RA and UA metabolites, which 
affect compound transfer mechanism and efficacy.   
 
In conclusion, RA was transferred across Caco-2 cells almost entirely in conjugated form, 
but UA was absorbed and transferred mostly intact, both independent of extract matrix.  
Our results predict no effect of plant matrix on the efficacy of either compound.  It will be 
important to measure the uptake of gut microbial metabolites of RA and effects of RA on 
expression of efflux transporters and tight junction proteins which would particularly affect 
a compound transferred paracellularly such as RA.  Cellular models of oral as well as 
intestinal uptake, metabolism and anti-inflammatory activity of RA and P. vulgaris and UA 
and S. officinalis will be of interest as well, given traditional uses of these herbs. 
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Figures 
                            
Rosmarinic acid                                 Ursolic acid                                   
                
Figure 1. The chemical structures of rosmarinic and ursolic acids.  
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Figure 2. The transport rate of ursolic acid for pure compound and S. officinalis extract 
across Caco-2 cell monolayer as a function of concentration at 5–20 μM after 4 h uptake 
study. S. officinalis extract was diluted to apply the same concentrations to the cells as were 
used for the pure compounds.  Data are the mean ± S. D (n=9).  Means bearing different 
letters were significantly different by ANOVA and Tukey’s multiple comparison (p < 
0.01). 
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Figure 3. Characteristics of transfer of rosmarinic (RA) and ursolic acids (UA) for pure 
compounds or plant extracts across Caco-2 cells before and after deconjugation of 
post-experimental basolateral solutions.  A. Before deconjugation. No RA was found at 
0.5 or 1 h.  Means bearing different letters were significantly different by ANOVA and 
Tukey’s multiple comparison (p < 0.01).  B. After deconjugation with 
β-glucuronidase/sulfatase; for RA and RA in P. vulgaris 27664.  C. Total basolateral 
recovery of RA and UA after deconjugation over 4 h incubation. * The basolateral 
recoveries of RA after β-glucuronidase/sulfatase incubation were significantly different 
from that before the enzyme treatment by two-sample t-test (p < 0.01).  Basolateral 
recoveries were calculated as the amount transported divided by the initial amount in the 
apical chamber during 4 h uptake study.  Data are the mean ± S. D (n=9).  
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Table 1. The contents of rosmarinic and ursolic acids in ethanol extracts of P. vulgaris and 
S. officinalis determined by HPLC. 
 
* Not detected.
 RA 
g/L (mM) 
UA 
g/L (mM) 
P. vulgaris 27664 (174.4 g/L) 8.4 ± 0.6 (23.3 ± 1.7) 0.1 ± 0.0 (0.2 ± 0.0) 
P. vulgaris 27665 (66.2 g/L) 3.2 ± 0.3 (9.0 ± 0.8) 0.1 ± 0.0 (0.1 ± 0.0) 
P. vulgaris 27748 (117.0 g/L) 19.9 ± 1.1 (55.2 ± 3.1) 0.6 ± 0.1 (1.0 ± 0.2) 
S. officinalis (10 g/L) ND* 2.6 ± 0.4 (5.8 ± 0.9) 
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Table 2. Apparent permeability coefficients (Papp) for lucifer yellow, rosmarinic acid, 
ursolic acid and extracts across the Caco-2 monolayer relative to deglucuronidation. 
 
a RA was 10 μM for pure compound and P. vulgaris extracts containing the same content of 
RA. b Papp of UA as a pure compound and in S. officinalis extract was calculated using 
non-toxic concentrations (5, 10 and 20 μM). 
c The Papp of rosmarinic and ursolic acids after treating with β-glucuronidase/sulfatase.  
* Significantly different compared with Papp of LY and RA by two-sample t-test (p < 0.01).  
† Significantly different before and after deconjugation by two-sample t-test (p < 0.01).  
--: not determined. 
 
 Before deconjugation After deconjugation c 
           LY 0.3 ± 0.1 -- 
RAa 0.2 ± 0.0 0.9 ± 0.2† 
RA in P. vulgaris 27664 0.2 ± 0.0 1.0± 0.4† 
RA in P. vulgaris 27665 0.2 ± 0.1 0.7 ± 0.1† 
RA in P. vulgaris 27748 0.1± 0.1 0.9± 0.1† 
UAb 2.8 ± 0.1* 2.4 ± 0.4* 
UA in S. officinalis  2.5 ± 0.4* 2.2 ± 0.6* 
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Abstract 
Our hypothesis was that caffeic acid derivatives, namely caffeic acid , rosmarinic acid, 
chlorogenic acid and m-hydroxyphenylpropionic acid (a microbial metabolite of caffeic 
acid and rosmarinic acid) altered the intestinal barrier and immune-modulators toward an 
anti-inflammatory profile in Caco-2 human intestinal epithelial cells and P-glycoprotein 
(P-gp) transporter, encoded by multidrug resistance (MDR1) gene, knockdown(KD) 
Caco-2 cells.  Stimuli composed of interleukin (IL)-1β, tumor necrosis factor (TNF)-α, 
interferon (IFN)-γ and lipopolysaccharides (LPS) were added to the cell system to 
represent the acute inflammatory reaction and mimic the inflammatory bowel disease.  
Transepithelial electrical resistance (TEER) across the monolayers increased rapidly 
during incubation with quercetin (positive control) and m-hydroxyphenylpropionic acid 
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(mHPP) after 12 h, and only chlorogenic acid and mHPP both at 50 µM showed protection 
against the reduction of TEER induced by the stimuli in Caco-2 cells.  In MDR KD 
Caco-2 cells, all treatment groups at 50 µM significantly augmented the TEER at each 
time-point compared with the control both with and without the stimuli, which was 
correlated with Lucifer yellow flux, a paracellular marker, across the cell monolayer.  
Immunoblot analysis of tight junction proteins revealed that caffeic acid derivatives at 50 
µM up-regulated ZO-1, ZO-2, claudin-1 and occludin in Caco-2 cells, and chlorogenic acid 
and mHPP were effective against the inflammatory stimuli induced reductionof ZO-2 and 
occludin, as well as induction of claudin-1 on tight junction proteins in Caco-2 cells.  
Caffeic acid derivatives up-regulated claudin-4 in MDR KD Caco-2 cells and only mHPP 
was effective against the inflammatory stimuli induced changes of tight junction protein 
expressions in MDR KD Caco-2 cells.  Caffeic acid derivatives at 50 µM significantly 
decreased the concentration of IL-6 in Caco-2 cells, but augmented TNF-α and IL-6 levels 
under the stimulated condition.  In MDR KD caco-2 cells plus the stimuli, all treatment 
groups significantly reduced both TNF-α and IL-6 concentrations.  These results suggest 
that P-gp plays an essential role in the anti-inflammatory activities of caffeic acid 
derivatives and mHPP exhibited greater enhancement of intestinal barrier function than the 
parent compounds.  
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Introduction 
Dietary polyphenols in fruit and vegetables are antioxidants and epidemiologic studies 
have shown a correlation between an increased consumption of phenolic antioxidants and a 
reduced risk of cardiovascular disease and certain types of cancer (Bravo, 1998).  Caffeic 
acid, one of the most common phenolic acids, frequently found in fruits, vegetables, grains 
and dietary supplements.  Chlorogenic acid is combined from caffeic and quinic acids in 
coffee and many types of fruits.  Rosmarinic acid is also a caffeic acid derivative found in 
many Lamiaceae herbs used commonly as culinary herbs such as rosemary, oregano and 
thyme.  Phenolic acids such as caffeic acid, chlorogenic acidand and rosmarinic acid 
(Figure 1) exhibit antioxidant, anti-inflammatory, anti-mutagenic and anti-carcinogenic 
effects in vitro (Rice-Evans et al., 1996; Scalbert, et al., 2002; Parnham and Kesselring, 
1985), therefore are of interest in inhibiting gastrointestinal inflammation which is relevant 
to inflammatory bowel disease (IBD) and colon cancer.  
 
Gastrointestinal epithelial cells provide a physical barrier to the diffusion of pathogens, 
toxins, and allergens from the lumen into the circulatory system.  In healthy individuals, 
the intestinal barrier is constituted of an intact layer of epithelial cells, which are tightly 
connected by a surrounding system of tight junction strands.  In IBD patients, epithelial 
barrier function is impaired (Gitter et al., 2001) with reduction of tight junction strands in 
ulcerative colitis and tight junction strand breaks in Crohn’s disease (Marin et al., 1983).  
Tight junction strands are formed by the assembly of a multiple-protein complex, which 
regulates the paracellular movement of ions, solutes, and water across the intestinal 
epithelium.  Four integral transmembrane proteins, occludin, claudins, junctional 
adhesion molecule, and tricellulin, have been identified (Furuse et al., 1993; Furuse et al., 
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1998; Ikenouchi, et al., 2005).  The intracellular domains of these transmembrane proteins 
interact with scaffold proteins, such as zonula occludens (ZO) proteins, which in turn 
anchor the transmembrane proteins to the perijunctional actomyosin ring.  Previous 
studies showed that some polyphenols, epigallocatechin gallate; genistein; myricetin; 
kaempferol and quercetin, enhance intestinal tight junctions in human intestinal Caco-2 
monolayers (Suzuki and Hara, 2010; Suzuki et al., 2011).  No studies have investigated 
the influences of phenolic acids on gut barrier functions, which might be the underlying 
mechanism of the protective effects of caffeic acid derivatives against colitis or colon 
cancer in animal models (Ye, et al., 2009; Tanaka, et al., 1990; Feng et al., 2010). 
 
Several inflammatory mediators are thought to be implicated in the development of IBD.  
The in vitro effects of interleukin (IL)-1β, tumor necrosis factor (TNF)- α, interferon (IFN)- 
γ and lipopolysaccharides (LPS) on intestinal epithelial cells have been shown to activate 
the intracellular cascades and increase the secretion of IL-6 (Vitkus et al., 1998), IL-8 
(Schuerer-Maly et al., 1994), prostaglandin E2 (PGE-2 , Wright et al., 2004) and nitric 
oxide (NO, Forsythe et al., 2002), as well as increase of the paracellular permeability 
through defects in tight junction assembly (Al-Sadi et al., 2007).  IL-1β, TNF-α, and IFN- 
γ have been found in increased concentrations in the intestinal tissue of IBD patients 
(Ligumsky et al., 1990; Reimund et al., 1996) and LPS plays a key role in the initiation of 
IBD because microflora may cause an initial inappropriate inflammatory stimulus if the 
intestinal cells are dysregulated, leading to an exaggerated cytokine presence and IBD 
development (Caradonna et al., 2000).   
 
P-gp transporter, encoded by multidrug resistance (MDR1) gene, plays a key role in drug 
absorption and distribution because it limits the permeability across the GI tract (Hunter 
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and Hirst, 1997) by active efflux of potentially toxic substances back into the intestinal 
lumen.  A great insight into the physiological role of P-gp protein in the GI tract has 
derived from the phenotype of the MDR1 gene knockout mice.  This model was prompted 
by the finding that the MDR1 gene is present in a region of the human genome (7q21.1) that 
may harbour a disease gene involved in susceptibility to IBD (Lathrop et al., 1996).  
Traditional herbs, such as Prunella vulgaris and Hypericum gentinoides, containing caffeic 
acid derivatives, have been found to act against the spontaneous colitis in MDR1 knockout 
mice in terms of increasing the survival percentage, elevating the anti-inflammatory 
cytokine and chemokines in serum and reducing typhlocolitis score (data not published), 
but the mechanism is unknown.   
 
This study was conducted to investigate the regulation of caffeic acid, rosmarinic acid, 
chlorogenic acid and m-hydroxyphenylpropionic acid (mHPP), a microbial metabolite of 
ingested caffeic acid or rosmarinic acid (Konishi and Kobayashi, 2004b; Konishi and 
Kobayashi, 2005), on tight junction proteins and immune modulators in both Caco-2 cell 
model and MDR knockdown (MDR KD) Caco-2 cells.  Stimuli composed of IL-1β, 
TNF-α, IFN- γ and LPS were added to Caco-2 cell system to represent the acute 
inflammatory reaction as it might occur during the active phase of IBD.  Our hypothesis 
was that caffeic acid derivatives altered the intestinal barrier and immune-modulators 
toward an anti-inflammatory profile and that the protection was stronger in MDR KD cells 
compared with Caco-2 cells. 
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Materials and methods 
Chemicals. Caffeic acid (98%), rosmarinic acid (90%), chlorogenic acid (95%), and 
m-hydroxyphenylpropionic acid (mHPP, 92%), a metabolite of caffeic acid derivatives, 
were obtained from Sigma-Aldrich Co. (St. Louis, MO).  Rabbit anti-claudin-1, claudin-4, 
ZO-1, ZO-2, and occludin were purchased from Zymed Laboratories (Gibco Invitrogen, 
Carlsbad, CA).  Mouse anti-α-tubulin was purchased from Sigma (St. Louis, MO).  
HRP-conjugated anti-mouse and -rabbit IgG were purchased from Zymed Laboratories.  
IL-1β, TNF-α, and LPS were purchased from Sigma-Aldrich Co. (St. Louis, MO), and 
IFN- γ was obtained from Invitrogen (Carlsbad, CA). 
 
Cell culture. Caco-2 cells were obtained from American Type Culture Collection (ATCC, 
Manassas, VA) at passage 18 and all experiments were performed from passages 35–45.  
MDR knockdown (MDR KD) Caco-2 cells (a gift from Dr. Kazuya Maeda, the University 
of Tokyo, constructed from Caco-2 cells from ATCC using siRNA technique, Watanabe et 
al., 2005) were used between passages 21 and 25.  The cells were cultured according to 
Hubatsch et al. (2007).  The cells were seeded on collagen-coated polytetrafluro- ethylene 
membrane inserts (0.45 μm) fitted in bicameral chambers (Transwell-COL, 24 mm ID, 
Corning Inc., Corning, NY) at 1.2 × 105 cells/cm2.  All experiments were conducted on d 
20-21 postseeding.  Stimuli composed of IL-1β (25 ng/mL), TNF-α (50 ng/mL) and IFN-γ 
(50 ng/mL) were applied at the basolateral side of the cells, and   LPS (1 µg/mL) was 
applied at both sides, representing on the one hand the common luminal microflora and, on 
the other hand, the increased presence of bacterial components in serum during IBD (Walle 
et al., 2010). 
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P-gp assay. P-gp activity was evaluated with fluorimetric measurement of the intracellular 
accumulation of calcein produced by ester hydrolysis of the P-gp substrate calcein-AM 
using VybrantTM Multidrug Resistance Assay Kit (Gibco Invitrogen, Carlsbad, CA) in 
Caco-2 and MDR KD Caco-2 cells.  After the cells in the flask grew to 90–100% 
confluency, cells were trypsinized and seeded on 96 well plates at 1.2 × 105 cells/cm2.  
Cells were preincubated for 15 min with or without the acknowledged P-gp modulator 
verapamil (10 µg/mL), thereafter calcein-AM was added and the fluorescence measured 
after 1 hour using microtiter plate reader Bio-Tek ELX 808 (Bio-Tek instruments. Inc., 
Winooski, VT) at 490 nm.   
 
Measurement of intestinal barrier function.  Intestinal barrier function was evaluated 
by measurement of transepithelial electrical resistance (TEER) and unidirectional flux of 
lucifer yellow (LY) across Caco-2 cell monolayers in transwells.  Caffeic acid, rosmarinic 
acid, chlorogenic acid, mHPP (10, and 50 µM) and quercetin (100 µM) were added to the 
apical wells and the cells were incubated for 48 h.  TEER was measured before and at 6, 12, 
24 and 48 h after administration of the caffeic acid derivatives by Millicell ERS meter 
(Fisher Sci., Pittsburgh, PA).  Lucifer yellow (LY, 100 µM), a paracellular marker, was 
added apically and the flux into the basolateral chamber was assessed before and after the 
experiment.  For LY quantification, the apical and basolateral solutions were transferred 
to a 96 well plate and read spectrophotometrically at 450 nm.  Whole cell extracts were 
prepared for immunoblot analysis of tight junction proteins after incubation for 48 h as 
described below.  Cytotoxicity of caffeic acid, rosmarinic acid, chlorogenic acid and 
mHPP was measured according to Nasser et al. (2008). 
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Assessment of Protein Expression by Western Blot Analysis. At the end of the 
experimental period, Caco-2 monolayers on the transwell were immediately rinsed with 
ice-cold PBS, and cells were lysed with lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM 
NaCl, 10 mM NaF, 5 mM EDTA, 2 mM sodium orthovanadate, 1 M phenylmethylsulfonyl 
fluorid, 3 mg/L leupeptin, 5 mg/L aprotinin, and 1% Triton X-100) and scraped, and the 
cell lysates were placed in microfuge tubes.  Cell lysates were centrifuged to yield a clear 
lysate.  Supernatant was collected, and total cellular protein was determined by Coomassie 
(Bradford) assay (Pierce Laboratories, Rockford, IL).  Laemmli gel loading buffer (6% 
SDS, 30% glycerol, 15% 2-b-mercaptoethanol, and 0.02% bromophenol blue in 188 mM 
Tris, pH 6.8) was added to the lysate containing 20 µg of protein and boiled for 7 minutes, 
after which proteins were separated on SDS-PAGE gel.  Proteins from the gel were 
transferred to polyvinylidene difluoride membranes.  Membranes were blotted for ZO-1, 
ZO-2, occludin, claudin-1, claudin-4 and α-tubulin using specific antibodies in 
combination with HRP-conjugated anti-mouse IgG or anti-rabbit IgG antibodies.  The 
blots were developed using the ECL chemiluminescence method (GE Healthcare, 
Piscataway, NJ).  Quantification was performed by using densitometric analysis of 
specific bands on the immunoblots. 
 
Determination of TNF-α and IL-6 secretion.  At the end of the experimental period, the 
extracellular media in the transwell were collected and centrifuged at 10,000 Xg for 10 min.  
TNF-α and IL-6 secretions were evaluated using a sandwich ELISA method (BD 
Biosciences Pharmingen, San Diego, CA) and quantified in pg/ml using the standard 
provided with the kit, with sensitivity limits being of 7.8 and 4.7 pg/ml, respectively for the 
TNF-α and IL-6 assay. 
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Statistical analysis Data are given as means ± S. D.  Differences in the percentage of the 
TEER relative to the initial value, lucifer yellow flux, tight junction protein density, , 
cytokine concentrations and fluorimetric intracellular accumulation of calcein were 
evaluated statistically using ANOVA and Tukey’s multiple comparison tests by SAS 9.1 
(SAS Institute Inc., Cary, NC).  Differences were considered significant at p < 0.05. 
 
Results 
P-gp activity in Caco-2 cells and MDR KD Caco-2 cells. As shown in Figure 2, 
P-gp-mediated efflux of calcein-AM, a substrate for P-gp, was significantly less in MDR 
KD Caco-2 cells with or without the treatment of P-gp inhibitor, verapamil, and in Caco-2 
cells incubated with verapamil, compared with Caco-2 cells (p < 0.05).  This indicates that 
the P-gp function in the MDR KD Caco-2 cells was almost completely inhibited. 
Caffeic acid derivatives enhance tight junction integrity in Caco-2 cells.  In Caco-2 
cells, 100 µM quercetin and 50 µM mHPP significantly increased TEER after 6 h and 12 h 
incubation, respectively, compared with control and caffeic acid, rosmarinic acid and 
chlorogenic acid (p < 0.05).  The TEER in all treatment groups was higher than that of 
control after 48 h incubation period (p < 0.05, Figure 3A).  This was correlated with the 
paracellular transport of LY, which was significantly reduced in all treatment groups 
compared with the control after 48 h incubation (data not shown).  After adding the 
stimuli, the TEER diminished up to 35% (data not shown) in controls compared with that 
without adding the stimuli (273 ± 15 vs 420 ± 11 Ω·cm2), and only chlorogenic acid and 
mHPP both at 50 µM showed protection against the adverse effects of the stimuli on the 
TEER (Figure 3B).  Fifty µM of caffeic acid, rosmarinic acid or chlorogenic acid 
exacerbated the diminishment of the TEER induced by the stimuli (Figure 3B), which was 
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correlated with LY flux across the Caco-2 cells (Figure 4A), indicating that quercetin, 
caffeic acid, and rosmarinic acid increased the permeability of the Caco-2 cells when the 
stimuli were added to initiate the inflammatory responses. 
 
In MDR KD Caco-2 cells, all treatment groups significantly augmented the TEER at each 
time-point compared with the control (p < 0.05, Figure 3C).  Interestingly, the elevation of 
the TEER by caffeic acid derivatives-incubated cells was greater than quercetin in MDR 
KD cells compared with Caco-2 cells (Figure 3A and C), supported by the flux of LY in to 
the basolateral side after 48 h incubation (data not shown).  After adding the stimuli in to 
MDR KD Caco-2 cells, the TEER was significantly reduced up to 29%  (321 ± 16 vs 453 ± 
23 Ω·cm2) in controls compared with that without adding the stimuli (data not shown), and 
all treatment groups significantly increased the TEER relative to the initial value compared 
with controls (p < 0.05, Figure 3D).  Among the treatment groups, mHPP showed greatest 
protection against the stimuli in the elevation of the TEER (p < 0.05), correlated with the 
flux of LY across the cell monolayer (Figure 3D and 4B). 
 
Caffeic acid induces the up-regulation of tight junction proteins.  After adding the 
stimuli, the expression of ZO-1, ZO-2 and occludin was all significantly decreased, and 
that of claudin-1 and claudin-4 increased in controls compared with without adding the 
stimuli (p < 0.05, Table 1 and 2).  Without the stimuli, the expression of ZO-1, ZO-2, 
claudin-1 and occludin in Caco-2 cells was increased by 50 µM of caffeic acid derivatives 
(p < 0.05, Table 1), but not at 10 µM (data not shown).  After adding the stimuli, 
chlorogenic acid and mHPP exhibited reversal of the response to inflammation: 
up-regulated ZO-1 (not for mHPP), ZO-2 and occludin, as well as down-regulated 
claudin-1 expressions compared with controls.  But this protection was not found for 
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claudin-4 in caffeic acid derivative treated Caco-2 cells, while quercetin at 100 µM 
attenuated the effect of the stimuli on the expression of claudin-4.  
 
In MDR KD Caco-2 cells after adding the stimuli, similar trend of the changes of tight 
junction proteins in controls was found in MDR KD Caco-2 cells, compared with Caco-2 
cells.   No treatment effect was found for ZO-1, ZO-2 and occludin (p > 0.05).  Quercetin, 
chlorogenic acid and mHPP increased claudin-1 expression and all treatment groups 
increased claudin-4 expression.  Caffeic acid derivatives significantly increased the 
expression of ZO-1 (not for chlorogenic acid) and occludin, and reduced the expression of 
claudin-1 and claudin-4 induced by the stimuli.  Only mHPP was effective in the elevation 
of the expression of ZO-2 in MDR KD cells with stimuli (Table 2).  
 
Caffeic acid derivatives reduced TNF-α and IL-6 in MDR KD Caco-2 cells.  TNF-α 
and IL-6 were not detected in Caco-2 cells both with or without treatment with caffeic acid 
or its derivatives (data not shown).  After adding the stimuli, TNF-α and IL-6 increased to 
357.6 ± 14.1 pg/mL and 6.3 ± 1.8 pg/mL in controls in Caco-2 cells.  Rosmarinic acid and 
mHPP increased TNF-α and IL-6 concentrations compared with other treatments (Table 3).   
 
In MDR KD Caco-2 cells, the level of TNF-α and IL-6 in control was greater than that in 
the Caco-2 cells (Table 4).  After adding the stimuli, the level of TNF-α and IL-6 in 
controls further increased (Table 5).  All treatment significantly reduced the concentration 
of TNF-α compared with control, while no treatment effect was found for IL-6 in MDR KD 
Caco-2 cells without stimuli (Table 4).  After adding the stimuli, all treatments 
significantly decreased both cytokine concentrations (Table 5).  
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Transepithelial transfer of caffeic acid derivatives across Caco-2 and MDR KD 
Caco-2 cells.  Basolateral recoveries of caffeic acid and mHPP were 4 fold and 3.3 fold 
greater in MDR KD Caco-2 cells than that in Caco-2 cells.  The amount of caffeic acid and 
mHPP in MDR KD Caco-2 cell lysates was ~3 fold higher than that in Caco-2 cells.  But 
no significant difference was found for the amount of quercetin, rosmarinic acid and 
chlorogenic acid in both basolateral side and cell lysates between Caco-2 and MDR KD 
Caco-2 cells (Table 6).  These results suggest that caffeic acid and mHPP, but not 
quercetin, rosmarinic acid and chlorogenic acid, might be substrates for P-gp transporter. 
 
Discussion 
This study demonstrated that caffeic acid derivatives enhanced tight junction integrity 
through the expression of tight junction proteins in both Caco-2 cells, which are widely 
used to study the intestinal epithelium, and in MDR KD Caco-2 cells.  The increment of 
TEER induced by caffeic acid derivatives was evidenced by the increase of the tight 
junction protein expression.  Although the precise mechanisms underlying caffeic acid 
-mediated promotive effect on tight junction integrity remain to be clarified, P-gp seems 
important in the regulation of both tight junction proteins and immunomodulators.  mHPP 
exhibited greater enhancement of intestinal barrier function than other caffeic acid 
derivatives, indicating the key role of this metabolite formed by microbes on the protection 
of gut function in vivo. 
 
Tight junction proteins bound to the actin cytoskeleton have a pivotal role in tight junction 
integrity.  Tight junction protein levels correlate with the permeability of tight junction in 
the epithelium (Betanzos et al., 2003; Basuroy, et al., 2006).  The caffeic acid 
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derivatives-mediated increase of TEER was related to the increased ZO-1, ZO-2, occludin, 
and claudin-1, but not claudin-4 in Caco-2 cells.  The flux of LY through paracellular 
pathway was reduced as expected, in conjuction with increased occludin which seemingly 
made the paracellular barrier tighter.  These results indicate that the assemblies of these 
four proteins at the tight junction are responsible for the caffeic acid derivatives-mediated 
promotion of intestinal barrier function.   
 
The intestinal inflammatory response requires the correct integration of the various signals 
that are released or received by the different cell types present in the gut (Van de Walle et 
al., 2010).  The regulated expression of a specific array of proinflammatory cytokines in 
intestinal epithelial cell lines suggests that these cells are programmed to provide 
chemotactic and activating signals to adjacent and underlying immune and inflammatory 
cells in the initial period following microbial invasion of epithelial cells and further serve to 
amplify the mucosal inflammatory response (Jung et al., 1995).  In our study, a cocktail 
composed of IL-1β, TNF-α, IFN- γ and LPS was utilized to represent the acute 
inflammatory reaction as it might occur during the active phase of IBD.  After adding the 
cocktail, the expressions of claudin-1 and 4 were significantly increased, while those of 
ZO-1, ZO-2 and occludin were significantly reduced compared with that without stimuli 
treatment (Table 1).  Previous studies in cultured monolayers and animal models have 
demonstrated that TNF-α which is central to Crohn disease pathogenesis, causes tight 
junction barrier dysfunction, such as induction of the expression of claudins via a process 
that requires myosin light chain kinase (MLCK) activation (Watterson et al., 2005; 
Zolotarevsky et al., 2002) and reduction of occludins by endocytosis of the specific protein 
(Wang et al., 2005), which in turn lead to the development of transient leaks and increases 
of the number of small pores (Weber et al., 2010).  MLCK activation is observed in 
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intestinal epithelia of patients with active IBD (Blair et al., 2006) and increased claudin-1 
and claudin-4 expression has also been reported in intestinal epithelial cells of patients with 
IBD (Heller et al., 2005).  Therefore, the use of a cocktail of inflammatory stimuli at 
plausible concentrations on differentiated Caco-2 cells was aimed to better reflect the in 
vivo situation during ongoing IBD. 
 
Among the tested caffeic acid derivatives, only chlorogenic acid and mHPP showed 
protection of the intestinal barrier function in terms of acting against the suppression of 
ZO-1, ZO-2 and occludin, as well as the induction of claudin-1 induced by the 
inflammatory stimuli in Caco-2 cells (Table 1).  Our finding of the influence of caffeic 
acid derivatives on tight junction proteins is novel in showing this role of phenolic acid in 
gut barrier protection.  Previous studies showed that two flavonoids, quercetin and 
kaempferol, promoted the assembly of tight junction proteins, claudin-1, occludin, and 
ZO-2, and the expression of claudin-4 through the inhibition of PKC.  In our study, caffeic 
acid derivatives, belonging to phenolic acids, were also able to promote the gut barrier 
function both with and without inflammatory stimuli, and the mechanism might be similar 
to the flavonoids, because caffeic acid at 70 µM inhibited phosphorylase kinase (PhK), 
protein kinase A (PKA), and PKC by about 90, 59, 57% in vitro, similar to quercetin 
(Nardini et al., 2000).  However, we can not rule out that caffeic acid derivatives may act 
differently compared with flavonoids as they are ionic in a neutral media (DMEM at pH 7.4 
in our study), which might explain the different response of claudin-4 to phenolic acids vs. 
flavonoids, because claudin-4 creates an “electrostatic selectivity filter” controlling overall 
resistance and charge selectivity of the small pores (Anderson et al., 2009).  Over 
expression of claudin-4 in Madin-Darby Canine Kidney (MDCK) epithelial cell lines 
decreased transmonolayer conductance by decreasing paracellular Na+ permeability 
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without affecting permeability for Cl– or flux for a noncharged solute.  Therefore, 
overexpression of a claudin can confer paracellular ionic discrimination (Van Itallie et al., 
2001).  Further, in our study, over-expressing claudin-4 did not stimulate an overall 
increase in the levels of other tight-junction components in MDR KD Caco-2 cells (Table 
2), consistent with previous studies showing that in epithelial cells claudin-1 and claudin-4 
can assemble into tight junction strands without the participation of either ZO-1 or occludin 
in MDCK cells (McCarthy et al., 2000; Van Itallie et al., 2001).  One possible role for the 
ZO proteins is to scaffold the integral membrane proteins and link them to the actin 
cytoskeleton (17).  That levels of occludin and ZO measured do not diminish in the face of 
claudin-4 over-expression suggests that claudin-4 does not act to replace these integral 
membrane tight junction proteins, but adds to them (Van Itallie et al., 2001).   Occludin is 
an integral part of tight junction strands (Fujimoto, 1995), but not essential for strand 
assembly because occludin deficient embryonic stem cells formed tight junctions (Saitou et 
al., 1998).  Therefore, future studies should focus on the molecular mechanism of the 
regulation of caffeic acid derivatives on claudins because the claudin family not only define 
tight junction permeability and affect barrier function, but also enhance cell proliferation 
and regeneration, neoplastic transformation, tumor growth and metastasis in experimental 
models (Dhawan et al., 2005). 
 
Of the several transport pumps investigated, MDR1 (i.e., P-gp) has been studied the most 
extensively in the context of overcoming chemo-resistance.  Interestingly, P-gp was also 
proposed to function as a ‘gatekeeper’ at different tissue barriers.  In our study, MDR KD 
Caco-2 cells responded differently compared with Caco-2 cells after exposure to caffeic 
acid derivatives in that only claudins were up-regulated but not for ZO and occludins.  The 
interaction between P-gp transporter and tight junction proteins in intestinal cells is 
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unknown yet; but in blood testis barrier, P-gp co-localizes with several tight junction 
proteins such as occludin, claudin-11, JAM, ZO-1, N-cadherin and β-catenin.  Meanwhile, 
P-gp co-localized and co-immunoprecipitated with actin, as well as with ezrin, radixin and 
moesin (ERM), a small family of adaptor proteins involved in linking tight junction 
proteins to actin filaments (Luciani et al., 2002).  In our study, when MDR gene was 
knocked down, the up-regulation of caffeic acid derivatives on ZO and occludin proteins 
disappeared, while enhancement of claudin-4 occurred compared with Caco-2 cells with 
high expression of P-gp transporter (Table 2).  This indicates that P-gp–actin interactions 
might be lost after the knockdown of MDR gene and that actin and ERM binding might be 
critical for caffeic acid derivatives to exhibit their protection, as well as that regulation of 
claudins, which are essential for forming tight junction strands, might be different with 
occludin and ZO proteins, which were indicated to be regulated by prolonged actin–myosin 
contraction produced contractile forces (Yao and Tsirka, 2011).  
 
Intestinal epithelial cells produce various inflammatory mediators and participate in the 
development of intestinal inflammation.  One of our key findings is that 50 µM of caffeic 
acid derivatives enhanced IL-6 and rosmarinic acid and mHPP augmented TNF-α secretion 
in intestinal epithelial cells after inflammatory stimulation (Table 1).  Caffeic acid did not 
have significant inhibitory effects on stimulated cytokines in the present study, although 
caffeic acid phenethyl ester and methyl ester, in the range of 25-100 µM, inhibited the 
translocation of the transcription factor nuclear factor kappa B (NF-κB) and subsequent 
production and release of TNF-α in LPS induced RAW264.7 cells (Shin et al., 2004).  This 
may be due to lower membrane permeability of caffeic acid compared with its more 
lipophilic esters.  Previous studies showed that 3 µM rosmarinic acid down-regulated the 
levels of TNF-α, IL-6, and high-mobility group box 1 protein, inhibited the IκB kinase 
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pathway, and modulated NF-κB in LPS induced RAW264.7 cells or human gingival 
fibroblasts (Jiang et al., 2009; Zdarilová et al., 2009).  In our study, rosmarinic acid and 
mHPP both at 50 µM exaggerated rather than attenuated the excretion of TNF-α and IL-6 
under the stimulated condition (Table 3).  This difference might be due to the tested cell 
lines or the stimuli applied to the model.  We utilized the endogenous mediators IL-1β, 
TNF-α, and IFN- γ whose mucosal levels are increased during IBD as well as exogenous 
LPS (Fais et al., 1991; Reimund et al., 1996; Caradonna et al., 2000) concomitantly affect 
the inflammatory response in intestinal epithelial cells.  The concentration of LPS used in 
our study (1 µg/mL) was greater than Jiang’s study (0.1 µg/mL alone, 2009).   Thus, 
caffeic acid derivatives may excerbate the inflammatory situation when stimuli were 
presented at the intestinal epithelial cells. 
 
More interestingly, when P-gp transporter, encoded by MDR gene, was knocked down in 
Caco-2 cells, all treatments attenuated the inflammatory responses initiated by the stimuli 
in terms of the reduction of TNF-α and IL-6 levels (Table 4).  There might be two reasons 
for the stronger inhibition of caffeic acid derivatives on the inflammatory responses.  First, 
tested compounds might more easily enter the cells to exhibit their anti-inflammatory 
activities, which was proved by the finding that cellular content of caffeic acid and mHPP 
in the basolateral side and cell lysates of MDR KD Caco-2 system was ~3 fold greater than 
that in Caco-2 cells both with or without the stimuli (Table 6), but not for rosmarinic acid 
and chlorogenic acid, whose transport across the cell monolayer was mainly via 
paracellular pathway (Konishi and Kobayashi, 2004; Konishi and Kobayashi, 2005).  
Secondly, several transcription factors, such as pregnane X receptor, constitutive 
androstane receptor, NF-κB, activator protein 1, etc., function as regulators for most ABC 
transporter proteins, i.e. P-gp, multidrug resistance-associated protein, organic anion 
142 
   
 
transporter, etc.  So knockdown of the MDR gene might affect transcriptional cascades 
that in turn affect inflammatory mediators.   
 
In conclusion, caffeic acid derivatives enhanced barrier function in human intestinal 
Caco-2 cells and mHPP exhibited greater enhancement of intestinal barrier than the parent 
compounds.  P-gp plays an essential role in the anti-inflammatory activities of caffeic acid 
derivatives.  The present findings would suggest that the caffeic acid derivatives could be 
gut health promoting as a dietary constituent, but the activities under inflammatory 
situation might need further mechanistic or in vivo studies. Moreover, intake of caffeic acid 
derivatives might speed up mucosal recovery or provide protection to the small-intestinal 
mucosa against the inflammatory mediators when P-gp inhibitors are co-administered, 
which are attractive from a therapeutic point of view.   In view of the abundance and 
possible medicinal properties of plant or food derived polyphenols, this field deserves 
continuing studies to ascertain any actual therapeutic benefits in humans. 
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Figures  
 
 
Figure 1.  The chemical structures of caffeic acid, rosmarinic acid, chlorogenic acid and 
m-hydroxyphenylpropionic acid (mHPP).  
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Figure 2.  P-glycoprotein transporter activity in Caco-2 cells and multidrug resistance 
(MDR) gene knockdown (KD) Caco-2 cells.   Verapamil was used as positive control at 
10 µg/mL.  Data are the mean ± S. D (n=6).  Means bearing different letters were 
significantly different by ANOVA and Tukey’s multiple comparison (p < 0.05). 
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Figure 3.  TEER in Caco-2 cell monolayers incubated with or without caffeic acid 
derivatives (50 µM) and quercetin (100 µM).  (A) Caco-2 cells; (B) Caco-2 cells treated 
with the stimuli composed of IL-1β (25 ng/mL), TNF-α (50 ng/mL), IFN-γ (50 ng/mL) and 
LPS (1 µg/mL) for 24hs; (C) MDR KD Caco-2 cells; (D) MDR KD Caco-2 cells treated 
with the stimuli composed of IL-1β (25 ng/mL), TNF-α (50 ng/mL), IFN-γ (50 ng/mL) and 
LPS (1 µg/mL) for 24hs.  Control was 0.3 % DMSO in DMEM.  Values are expressed as 
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means ± SD, n = 4.  Means bearing different letters at a time were significantly different 
by ANOVA and Tukey’s multiple comparison (p < 0.05).
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Figure 4.  Lucifer yellow flux across cell monolayers incubated with or without caffeic 
acid derivatives (50 µM) and quercetin (100 µM) for 48 h incubation. (A) Caco-2 cells 
treated with the stimuli composed of IL-1β (25 ng/mL), TNF-α (50 ng/mL), IFN-γ (50 
ng/mL) and LPS (1 µg/mL) for 24 hs; (C) MDR KD Caco-2 cells treated with the stimuli 
composed of IL-1β (25 ng/mL), TNF-α (50 ng/mL), IFN-γ (50 ng/mL) and LPS (1 µg/mL) 
for 24 hs.  Control was 0.3 % DMSO in DMEM.  Values are expressed as means ± SD, n 
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= 4.  Means bearing different letters were significantly different by ANOVA and Tukey’s 
multiple comparison (p < 0.05).  The dash line indicates the baseline of lucifer yellow 
flux across cell monolayers in each cell type.  
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Table 1. Immunoblot analysis of tight junction proteins in the whole extracts of Caco-2 
cells incubated with caffeic acid derivatives (50 µM) and quercetin (100 µM) for 48 hs, 
quantitated by densitometric analysis a.   
 Control Quercetin Caffeic 
acid 
Rosmarinic 
acid 
Cholorogenic 
acid 
mHPP 
ZO-1 2.2 ± 0.1d 2.3 ± 0.2d 2.9 ± 0.1b 3.3 ± 0.2a 2.5 ± 0.2c 2.9 ± 0.1b 
 1.3 ± 0.1f 1.1 ± 0.1g 1.4 ± 0.2f 1.5 ± 0.2f 1.7 ± 0.3e 1.3 ± 0.1f 
ZO-2  0.4 ± 0.01b 0.5 ± 0.01a 0.5 ± 0.01a 0.5 ± 0.02a 0.5 ± 0.02a 0.5 ± 0.02a 
 0.3 ± 0.01c 0.3 ± 0.03c 0.3 ± 0.02c 0.4±0.03b 0.4±0.02b 0.5±0.01a 
Claudin -1 0.6 ± 0.01f 0.7 ± 0.01cde 0.7 ± 0.01de 0.7 ± 0.02e 0.7 ± 0.02de 0.7 ± 0.02de 
 0.7 ± 0.02bcd 0.7 ± 0.01bc 0.7 ± 0.01b 0.8 ± 0.04a 0.6 ± 0.03f 0.6 ± 0.03f 
Claudin -4 0.3 ± 0.02g 0.4 ± 0.01f 0.3 ± 0.01g 0.3 ± 0.01g 0.3 ± 0.01g 0.3 ± 0.03g 
 0.6 ± 0.01d 0.4 ± 0.02e 0.6 ± 0.01d 0.7 ± 0.02b 0.7 ± 0.04a 0.6 ± 0.01c 
Occludin 11.7 ± 0.02f 12.3 ± 0.02e 12.9 ± 0.1c 14.6 ± 0.2b 12.6 ± 0.3d 14.8 ± 0.08a
 10.6 ± 0.1h 11.7 ± 0.1f 7.6 ± 0.1j 9.4 ± 0.1i 11.7 ± 0.2g 14.6 ± 0.1b 
a BOLD denotes cells treated with inflammatory cocktail, which was composed of IL-1β 
(25 ng/mL), TNF-α (50 ng/mL), IFN-γ (50 ng/mL) and LPS (1 µg/mL) and incubated for 
24 hs.  The density values were normalized by the internal standard, α-tubulin.  Control 
was 0.3 % DMSO in DMEM.  Values are means ± SD, n = 4. Significant changes within a 
protein are noted by letters compared with untreated cells by ANOVA and Tukey’s 
multiple comparison (p < 0.05). 
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Table 2. Immunoblot analysis of tight junction proteins in the whole extracts of MDR KD 
Caco-2 cells incubated with caffeic acid derivatives (50 µM) and quercetin (100 µM) for 48 
hs, quantitated by densitometric analysis a.   
 Control Quercetin Caffeic acid Rosmarinic 
acid 
Cholorogenic 
acid 
mHPP 
ZO-1 1.8 ± 0.03a 1.7 ± 0.2a 1.9 ± 0.1a 1.7 ± 0.1a 1.7 ± 0.1a 1.7 ± 0.1a 
 1.4 ± 0.04b 1.7 ± 0.1a 1.7 ± 0.1a 1.7 ± 0.1a 1.5 ± 0.1b 1.7 ± 0.2a 
ZO-2 0.6 ± 0.01a 0.6 ± 0.01a 0.6 ± 0.01a 0.6 ± 0.05a 0.6 ± 0.07a 0.6 ± 0.02a 
 0.4 ± 0.01b 0.4±0.03b 0.4±0.01b 0.4±0.03b 0.4±0.01b 0.5±0.03a 
Claudin -1 0.7 ± 0.01c 0.9 ± 0.06b 0.6 ± 0.02c 0.7 ± 0.01c 0.8 ± 0.02b 0.7 ± 0.04b 
 1.0 ± 0.2a 0.8 ± 0.1b 0.7 ± 0.04c 0.8 ± 0.03bc 0.7 ± 0.03c 0.7 ± 0.01c 
Claudin -4 0.6 ± 0.04g 0.7 ± 0.01c 0.6 ± 0.01d 0.7 ± 0.01b 0.7 ± 0.02d 0.7 ± 0.01bc 
 0.7 ± 0.01bc 0.8 ± 0.02a 0.6 ± 0.02de 0.6 ± 0.01fg 0.6 ± 0.01ef 0.6 ± 0.01ef 
Occludin 11.2 ± 0.08a 11.2 ± 0.06a 11.1 ± 0.5a 11.2 ± 0.3a 11.1 ± 0.3a 11.0 ± 0.04a 
 4.8 ± 0.3e 4.7 ± 0.1e 7.3 ± 0.02b 5.7 ± 0.1d 6.3 ± 0.1c 7.7 ± 0.1b 
a BOLD denotes cells treated with inflammatory cocktail, which was composed of IL-1β 
(25 ng/mL), TNF-α (50 ng/mL), IFN-γ (50 ng/mL) and LPS (1 µg/mL) and incubated for 
24 hs.  The density values were normalized by the internal standard, α-tubulin.  Control 
was 0.3 % DMSO in DMEM.  Values are means ± SD, n = 4. Significant changes within a 
protein are noted by letters compared with untreated cells by ANOVA and Tukey’s 
multiple comparison (p < 0.05). 
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 Table 3. Caffeic acid derivatives (50 µM, 48 h incubation) augmented the inflammatory 
responses after treating Caco-2 cells with the stimuli a. 
 TNF-α (pg/mL) IL-6 (pg/mL) 
Control 357.6 ± 14.1b 6.3 ± 1.8c 
Quercetin 486.2 ± 95.4ab 16.8 ± 2.1a 
Caffeic acid 517.0 ± 193.5ab 9.8 ± 0.3b 
Rosmarinic acid 665.1 ± 8.6a 21.2 ± 6.6a 
Chlorogenic acid 338.6 ± 1.7b 9.1 ± 5.2a 
mHPP 604.4 ± 27.3a 18.3 ± 1.0a 
a Values are means ± SD, n = 4.  Control was 0.3 % DMSO in DMEM.  Means bearing 
different letters were significantly different within each column by ANOVA and Tukey’s 
multiple comparison (p < 0.05).  Stimuli were composed of IL-1β (25 ng/mL), TNF-α (50 
ng/mL), IFN-γ (50 ng/mL) and LPS (1 µg/mL) and incubated for 24 hs.  
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Table 4. Caffeic acid derivatives (50 µM, 48 h incubation) attenuated the inflammatory 
responses in MDR KD Caco-2 cells a. 
 a Values are means ± SD, n = 4.  Control was 0.3 % DMSO in DMEM.  Means bearing 
different letters were significantly different within each column by ANOVA and Tukey’s 
multiple comparison (p < 0.05).  ND= Not detected.  The limit of detection was 7.8 and 
4.7 pg/ml for the TNF-α and IL-6 assay, respectively. 
 TNF-α  (pg/mL) IL-6 (pg/mL) 
Control 63.2 ± 28.3a 15.2 ± 0.7ab 
Quercetin ND 16.4 ± 0.2ab 
Caffeic acid ND 18.1 ± 0.4a 
Rosmarinic acid ND 20.7 ± 2.7 a 
Chlorogenic acid ND 11.4 ± 0.1b 
mHPP ND 20.3 ±4.5a 
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Table 5. Caffeic acid derivatives (50 µM, 48 h incubation) attenuated the inflammatory 
responses in MDR KD Caco-2 cells treated with the stimuli a. 
a Values are means ± SD, n = 4.  Control was 0.3 % DMSO in DMEM.  Means bearing 
different letters were significantly different within each column by ANOVA and Tukey’s 
multiple comparison (p < 0.05).  ND= Not detected.  Stimuli were composed of IL-1β (25 
ng/mL), TNF-α (50 ng/mL), IFN-γ (50 ng/mL) and LPS (1 µg/mL) and incubated for 24 hs.  
The limit of detection was 7.8 and 4.7 pg/ml for the TNF-α and IL-6 assay, respectively. 
 TNF-α (pg/mL) IL-6 (pg/mL) 
Control 122.2 ± 12.3a 27.9 ± 4.6a 
Quercetin ND 11.3 ± 5.4b 
Caffeic acid ND 8.4 ± 0.2b 
Rosmarinic acid ND 11.4 ± 1.2b 
Chlorogenic acid ND 8.3 ± 2.1b 
mHPP ND 8.4 ± 1.0b 
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Table 6. Transfer of quercetin (100 µM) and caffeic acid derivatives (50 µM) across 
Caco-2 and MDR KD Caco-2 cells a. 
a Values are the mean ± SD (n=4).  Control was 0.3 % DMSO in DMEM.  * indicates 
significant difference between Caco-2 and MDR KD Caco-2 cells by two-sample t-test (p < 
0.05).  ND= Not detected.  % represents the recovery relative to the initial amount. 
 
 
 Basolateral side Cell lysate 
 Caco-2 (%) MDR KD (%) Caco-2 (%) MDR KD (%) 
Quercetin 3.3 ± 0.7   4.2 ± 1.4 0.2 ± 0.1 0.3 ± 0.1 
Caffeic acid 2.4 ± 0.2 9.6 ± 0.3* 0.5 ± 0.3 1.8 ± 0.4* 
Chlorogenic acid 1.3 ± 0.5 2.3 ± 1.1 ND ND 
Rosmarinic acid 0.9 ± 0.2 1.1 ± 0.4 ND ND 
mHPP 2.5 ± 0.6 8.4 ± 1.4* 0.7 ± 0.3* 2.2 ± 0.6* 
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CHAPTER 6. GENERAL CONCLUSIONS 
General Discussion 
A major limiting step in the utilization of herbal constituents is their intestinal absorption 
and metabolism.  Compound passes across the intestinal epithelium via passive diffusion, 
both paracellularly and transcellularly, and by active transport.  After entering the cells, 
herbal constituents may undergo Phase I and II biotransformation by metabolizing 
enzymes; the parent compounds and the metabolites are effluxed to the apical side (luminal) 
or transported to the basolateral side (systemic) by various transporters located at both sides 
of the intestinal epithelial cells.  In addition, herbal constituents might also have influences 
on the metabolizing enzyme activities or the expression and function of transporters, which 
in turn affects the bioavailability of other herbal constituents or dietary nutrients, indicating 
possible herb-herb and herb-drug interactions.  Furthermore, caffeic acid derivatives from 
diet or tranditional herbs have been reported to have anti-inflammatory properties both in 
vitro and in vivo.  Chapter 3, 4 and 5 are original projects which were performed on 
permeability and metabolism of herbal constituents and modulation of caffeic acid 
derivatives on intestinal function in Caco-2 cell line.  
 
In Chapter 3, we have conducted the study of transport mechanism and metabolism of 
alkamides and ketone in Echinacea species and their inhibitory activites on P-glycoprotein 
transporter (P-gp) function.  Tested alkamides transport the Caco-2 cell monolayer via 
passive diffusion, independent of the plant matrix, and were seemingly N-glucuronidated 
both as pure compounds and as found in E. saguinea and E. pallida extracts.  Both 
Echinacea extracts stimulated apparent glucuronidation and basolateral efflux of alkamide 
metabolites.  Interestingly, E. pallida ethanol extract inhibited the efflux of glucuronides 
of Bauer alkamides apically (lumin) while inducing the transfer of the conjugates 
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basolaterally (systemic), and the phytochemical profile might contribute to the difference 
between two Echincea species.  It was not expected that Bauer ketone 24 was totally 
metabolized to more hydrophilic metabolites as a pure compound, but not as found in either 
Echinacea species, indicating the influences of plant matrix on ketone metabolism in 
Caco-2 cells.  We found that Bauer alkamide 8, 10 and 11 at 175-230 µM, E. sanguinea at 
1 mg/mL (containing 85 µM of alkamide 8, 2 µM of alkamide 10, and 0.7 µM of alkamide 
11) and E. pallida at 5 mg/mL (containing 215 µM of alkamide 8, 25 µM of alkamide 10, 
and 45 µM of alkamide 11) significantly inhibited P-gp function.  Taken together, plant 
matrix had a facilitating effect on the metabolism and efflux of alkamides and ketones from 
Echinacea, and that alkamides and Echinacea extracts might be useful in potentiating some 
chemotherapeutics which are substrates for P-gp. 
 
In Chapter 4, we have investigated the permeabilities and Phase II biotransformation of 
rosmarinic acid and ursolic acid as pure compounds and in herbal extracts using Caco-2 
cells with HPLC detection.  We found increased basolateral rosmarinic acid recoveries 
after deconjugation indicating that glucuronide/sulfate conjugates were excreted to the 
basolateral side (toward the circulation) rather than apical side (the intestinal lumen).  In 
addition, the plant extracts, P. vulgaris and S. officinalis, did not affect transfer of either 
ursolic acid or rosmarinic acid, and likewise the pure compounds and the compounds from 
the plant extracts behaved similarly in their apparent biotransformation as well, which was 
different compared with alkamide metabolism in pure solutions vs. Echinacea species.  
This difference might be due to the transport mechanism (paracelluar diffusion for 
rosmarinic acid vs. transcellualr diffusion for alkamides) and phytochemical profile of P. 
vulgaris and Echinacea species.  Meanwhile, ursolic acid was absorbed and transferred by 
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Caco-2 cells apparently with little glucuronidation/sulfation, which is likely to further 
enhance the bioavailability of ursolic acid compared with rosmarinic acid.   
 
In Chapter 5, we performed the regulation of caffeic acid, rosmarinic acid, chlorogenic acid 
and m-hydroxyphenylpropionic acid (mHPP), a microbial metabolite of ingested caffeic 
acid, chlorogenic acicd or rosmarinic acid, on tight junction proteins and immune 
modulators in both Caco-2 cell model and multidrug resistance (MDR) knockdown (MDR 
KD) Caco-2 cells.  Stimuli composed of IL-1β, TNF-α, IFN- γ and LPS were added to 
Caco-2 cell system to represent the acute inflammatory reaction as it might occur during 
the active phase of IBD.  We found that caffeic acid derivatives enhanced tight junction 
integrity through the expression of tight junction proteins in both Caco-2 cells and MDR 
KD Caco-2 cells.  Among the tested caffeic acid derivatives, we reported for the first time 
that mHPP exhibited greater enhancement of intestinal barrier than the parent compounds, 
indicating that mHPP deserves more studies.  One of our key findings was that 50 µM of 
caffeic acid derivatives were found to be enhancers of IL-6 and rosmarinic acid and mHPP 
augmented TNF-α secretion in intestinal epithelial cells after stimulation.  More 
interestingly, when P-gp transporter, encoded by MDR gene, was knocked down in Caco-2 
cells, all cafffeic acid derivatives attenuated the inflammatory responses initiated by the 
stimuli in terms of the reduction of TNF-α and IL-6 levels, implying that knockdown of the 
MDR gene might affect transcriptional cascades that in turn affect inflammatory mediators.  
 
As a conclusion, alkamides, ketone, RA and UA in herbal extracts was transported across 
Caco-2 cell monolayer with different permeability rates.  The metabolism was a complex 
process, especially in different Echinacea species.  Caffeic acid derivatives could be gut 
health promoting as dietary constituents, and mHPP was deserved the promising research 
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future in both anti-inflammatory and anti-oxidative areas, particularly in molecular 
mechanism related to revealing anti-colitic pathway.
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Recommendations for Future Research 
 
In Caco-2 transport study, glucuronide conjugates of herbal alkamides, ketones, and caffeic 
acid derivatives were found, and plant matrix had influences on the metabolism and efflux 
of the metabolites of alkamides based on the current preliminary result.   As a next step, 
we need to further investigate the inducibility of glucuronidation/sulfation, by herbal 
components as well as the expression of Phase I and II enzymes in Caco-2 cells after 
treating different pure compounds or herbal extracts.  The identification of the herbal 
constituent or combination of various components that have major effects on metabolizing 
enzymes and transporter functions are also required.  
 
With respect to the enhancement of caffeic acid derivatives on intestinal epithelial function, 
more mechanistic studies need to be carried out in the future.  More specifically, myosin 
light chain kinase (MLCK), protein kinase C (PKC), ezrin, radixin and moesin (ERM) and 
NF-κB pathways might be targeted to reveal the underlying mechanism of the protection of 
caffeic acid derivatives on intestinal barrier function.  
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